Datasets:

AutoIntent

/

events

like 0

Follow

AutoIntent Library 5

Take legal action against encroached lands - Cecilia Dapaah Sanitation and Water Resources minister, Cecilia Abena Dapaah Thu, 16 Sep 2021 ghanaiantimes.com The Minister of Sanitation and Water Resources, Cecilia Abena Dapaah, has directed the Ghana Water Company Limited (GWCL) to initiate legal processes to demolish structures on the companys encroached lands. In the meantime, she has asked the company to undertake regular patrol on lands to protect and prevent encroachers from taking over the lands. She said the company should collaborate with other stakeholders to create a 100-metre buffer around water bodies and their operational equipment and machinery. The minister was speaking in Accra yesterday when she inspected the progress of repair works at the Weija Treatment Plant. The plant has been shut down for five-day repair works by the GWCL which commenced on September 13, 2021. The exercise has resulted in a cut in the water supply to the western parts of the Greater Accra Region. Weija, Gbawe, Bortianor, Kokrobite, Kasoa, Mallam, Sakaman, Odorkor, Dansoman, Kaneshie, Achimota, Korlebu, Mataheko, and surrounding communities, were areas affected by the repair works. Madam Dapaah noted, however, that water supply to these areas will resume within 24 to 48 hours. She said the progress report received from the Engineers in charge indicated that the repair works, which bordered on the water pump and meter installation and welding of broken pipes, were about 90 percent complete. She commended GWCL for completing the works within the announced schedule as well as using both its internally generated funds and internal expertise to undertake the rehabilitation. Managing Director of GWCL, Dr Clifford Braimah, said repair works were undertaken regularly to avoid a total collapse of equipment, saying that the ongoing works would help the company to reduce the quantity of treated water lost through leakages. As part of measures to improve operations and revenue collection, he noted that the company was installing digital meters that could detect the illegal connections and provide accurate data on the quantity of water supplied to a location within a given period. He said 426 fixed meters and 226 industrial meters were being deployed across the country to help reduce losses Source:

View Comments Almost Heaven Ice Cream is doubling its size. A third location opened at the end of February in Hartville. And the family-owned business hopes to have a fourth location open later this year in Canal Fulton after acquiring Oser's Dairy & Deli. The sites are an addition to the original Almost Heaven locations at 6590 Middlebranch Ave. NE in Plain Township and the second site at 2154 Beechwood Ave. in Alliance. The string of ice cream parlors started in 2007 when Todd Truax opened the first location next door to Sonshine Medical, a medical equipment business the Truax family owns. The ice cream business started expanding five years ago when the Truax family bought property in Alliance to build a second location. They also built a new store in Hartville at 624 S. Prospect St. Jared Truax, Todd's son, said the family decided to build in Hartville because it's a destination town that draws people from outside the area for shopping. "It's a good, local community," he said. Plans were to open the Hartville location in early January, but supply chain issues delayed construction, Jared Truax said. The company had to wait on building supplies and equipment, he said. It's anticipated that supply chain delays will be a factor in getting the Canal Fulton location ready, Jared Truax said. He hopes to start work soon to convert from Oser's to the Almost Heaven theme, but expects it could be the end of summer before the location is ready to serve ice cream. Canal Fulton Mayor Joe Schultz said the city's Historic Preservation Commission will work with Almost Heaven on plans. Canal Fulton officials want to ensure there aren't drastic changes to buildings in the historic downtown district. According to county records, the building dates to 1890, while Oser's has been operating there since 1954. Schultz is happy to see Almost Heaven invest in downtown Canal Fulton. "We expect they'll be a good business partner for the community," he said. Jared Truax said the shop expects to maintain some of the 68 years of Oser's Dairy history. "We don't want to lose all of the heritage," he said. Until then, Almost Heaven's more than 20 ice cream flavors and other treats are available at the Plain Township, Hartville and Alliance locations. Ice cream makes folks happy and Jared Truax said he enjoys serving happy customers. "That's the best part of the business," he said. Diebold Nixdorf, McDonald's Germany expand IT service agreement McDonald's Germany and Diebold Nixdorf have expanded their IT service partnership agreement. The new agreement has Diebold Nixdorf installing and providing maintenance for equipment in new and upgraded restaurants at McDonald's Germany. The chain has more than 1,430 locations. It marks another milestone in the collaboration between the companies, which has seen Diebold Nixdorf self-service terminals and payment transaction technology. Diebold Nixdorf's equipment helps the restaurant chain meet German security regulations for point-of-sale systems. Diebold Nixdorf and McDonald's Germany have worked together for many years, and expanding the agreement was a logical step, especially because customer expectations for technology have grown in recent years, Nicolas von Sobbe, vice president for technology at McDonald's Germany, said in a press release. 415 Group opens Alliance office Accounting and business services firm 415 Group has opened an office in Alliance. The Jackson Township certified public accounting, business consulting and IT services firm said it added the office at 960 W. State St. to better serve customers in Alliance, Louisville, Minerva, Salem and Sebring. Joining 415 Group as tax director and leader of the Alliance office is Marcie Curry, who has 20 years experience in accounting. Housing sales flatten The number of properties sold in Ohio during February matched housing sales in February 2021, the Ohio Realtors reported. Real estate agents around the state reported selling 9,382 residences during February, the same number as last year. The average price on the properties increased by 11.9% to $235,359, the organization said. Real estate agents in MLS Now, which includes Stark and 22 other Northeast Ohio counties, reported selling 3,201 units in February, up less than 1% from 3,183 sold during the same period last year. The average price increased 11.2% to $204,625. During the first two months, real estate agents in the MLS Now group reported selling 6,592 residences, up 2.2% from 6,447 in 2021. Statewide, agents have sold 18,897 units, up less than 1% from 18,776 sold last year.

TSE:IBG opened at C$10.62 on Monday. IBI Group has a one year low of C$3.90 and a one year high of C$10.93. The stock has a market cap of C$332.03 million and a P/E ratio of 24.58. The company has a debt-to-equity ratio of 200.56, a current ratio of 1.79 and a quick ratio of 1.64. The company has a fifty day moving average price of C$10.40 and a 200 day moving average price of C$8.98. IBI Group (TSE:IBG) last announced its quarterly earnings data on Thursday, March 11th. The company reported C$0.01 earnings per share (EPS) for the quarter, missing analysts consensus estimates of C$0.12 by C($0.11). The firm had revenue of C$98.58 million for the quarter, compared to the consensus estimate of C$95.16 million. As a group, equities research analysts anticipate that IBI Group will post 0.75 EPS for the current year. IBI Group Company Profile IBI Group Inc provides various professional services in Canada, the United States, the United Kingdom, and internationally. Its professional services include urban design and planning, architecture, civil engineering, transportation engineering, traffic engineering, systems engineering, urban geography, real estate analysis, landscape architecture, communications engineering, software development, and other consulting services. See Also:

The revenue from operations came in at Rs 5,103 crore, up 8.3 per cent against Rs 4,711 crore in the corresponding quarter last year. 28 Jan, 2022, 01.08 PM IST Consolidated revenue from operations fell by about 11 per cent to Rs 43.37 crore during the reported quarter from Rs 61.8 crore earlier. 27 Jan, 2022, 10.02 PM IST Consolidated revenue for the December quarter stood at Rs 6,927 crore, up 3 per cent on-year while consolidated earnings before interest tax depreciation & amortization (Ebitda) also rose 3 per cent on-year to Rs 3,704 crore. 27 Jan, 2022, 09.17 PM IST The company's revenue from operations during October-December 2021 increased 3.84 per cent to Rs 1,271.29 crore, against Rs 1,224.21 crore in the year-ago period. 27 Jan, 2022, 04.45 PM IST L&T Q3 Results Preview: Analysts expect another weak quarter; order inflows to fall sharply Analysts at Sharekhan said L&T is expected to see muted net earnings on account of pressure on margins and lower other income year-on-year (YoY). The weak performance from L&T will also drag down the performance of the entire sector. 27 Jan, 2022, 04.05 PM IST Revenue from operations was at Rs 2,275.66, up 50.39 per cent from Rs 1,513.16 crore in the year-ago quarter. 27 Jan, 2022, 03.41 PM IST The drugmaker said its consolidated net profit declined by 16 per cent to Rs 249 crore for the quarter ended December 2021. The company had posted a net profit of Rs 297 crore in the October-December period of 2020-21 fiscal. 27 Jan, 2022, 11.15 AM IST Cipla gains despite YoY fall in Q3 profit as bottom-line surpasses estimates Cipla reported a 2.6 per cent decline in its consolidated profit after tax to Rs 729 crore for the third quarter ended on December 31, 2021. An ET NOW poll of analysts had estimated the net profit at Rs 710 crore. 27 Jan, 2022, 10.14 AM IST Revenues rose 6 per cent YoY to Rs 2,108 crore in Q3FY22 compared to Rs 1,995 crore in Q3FY21 25 Jan, 2022, 08.20 PM IST Its revenue from operations rose 7.64 per cent to Rs 8,854.5 crore, as against Rs 8,226 crore in the corresponding period of the previous fiscal. 25 Jan, 2022, 06.59 PM IST Total income rose to Rs 353 crore in the quarter under review from Rs 321.91 crore a year ago. 25 Jan, 2022, 06.56 PM IST Total revenue from operations was at Rs 5,478.86 crore against ET NOW poll of Rs 5,420 crore. 25 Jan, 2022, 06.04 PM IST The third-largest private bank in India reported a profit after tax of Rs 3,614.24 crore. The banks scrip rose to a high of Rs 715.60 against Rs 704.35 at the previous close on the BSE. 25 Jan, 2022, 09.41 AM IST Revenue from operations was up 71.51 per cent to Rs 279.89 crore during the quarter under review as against Rs 163.19 crore in the corresponding period of 2020-21. 24 Jan, 2022, 10.22 PM IST ETIG analysed a common sample of 254 companies that have already announced their earnings. The analysis showed that revenue climbed 28.4% for the companies under review, while net profit grew 17%. 24 Jan, 2022, 06.53 AM IST The consolidated revenue from operations during the period under review stood at Rs 1,068.23 crore against Rs 838.32 crore in the year-ago quarter, it added. 21 Jan, 2022, 05.15 PM IST Its revenue from operations grew 22.78 per cent to Rs 3,371.99 crore, compared with Rs 2,746.34 crore in the year-ago period. 21 Jan, 2022, 04.42 PM IST The widening of the consolidated loss in the December quarter was "due to non-operation of Nashik Thermal Power Plant (Sinnar Thermal Power Ltd). That exposure has no bearing on parent RattanIndia Power Ltd," a company spokesperson said. 21 Jan, 2022, 01.14 PM IST RIL Q3 Results Preview: Higher GRM may drive PAT; Jio ARPU seen at Rs 149 We expect consolidated profit after tax (PAT) to increase by 10 per cent sequentially led by strong growth in standalone business on higher gross refining margins (GRMs). Petchem margin, a decent performance by Jio led by telecom tariff hike and solid recovery in EBITDA of the retail business, said analysts at Sharekhan. 21 Jan, 2022, 10.49 AM IST Total income during the October-December quarter of the current fiscal rose to Rs 1,994.18 crore, from Rs 1,842.11 crore in the year-ago period. 20 Jan, 2022, 10.14 PM IST In what was an otherwise strong year for Tata Group stocks, Rallis India fell 2 per cent in 2021 and was the only Tata Group scrip to log negative returns. 20 Jan, 2022, 10.32 AM IST Its revenue from operations during October-December 2021 jumped 10.1 per cent to Rs 628.08 crore, against Rs 570.47 crore in the year-ago period. 19 Jan, 2022, 10.12 PM IST Saregama's revenue from operations was up 12.27 per cent to Rs 150.34 crore during the period under review as against Rs 133.91 crore in the corresponding period of the previous fiscal. 19 Jan, 2022, 03.11 PM IST Load More

Reporter, Puget Sound Business Journal Mar 17, 2022 U.S. regulators have approved Amazon.com Inc.'s (Nasdaq: AMZN) acquisition of MGM Studios, arming the tech giant's video streaming service with a catalog of thousands of movies and TV episodes. The Seattle-based company said Thursdaythat the $8.45 billion deal, announced less than a year ago has closed. The announcement was expected to come soon after the European Commission unconditionally approved the deal earlier this week and it was reportedthat U.S. antitrust regulators were facing a March 15 deadline. The deal is the second-largest in Amazon history behind the $13.7 billion it paid for Whole Foods in 2017. With it, Amazon will absorb franchises like "James Bond" and "Rocky." Amazon is using the studio to strengthen Prime Video, its streaming service that's included in a Prime membership, which recently raised its fees. It's also bringing Thursday Night Football to the platform in September. "MGM has a nearly century-long legacy of producing exceptional entertainment, and we share their commitment to delivering a broad slate of original films and television shows to a global audience," said Mike Hopkins senior vice president of Prime Video and Amazon Studios, in a company blog post. "We welcome MGM employees, creators and talent to Prime Video and Amazon Studios, and we look forward to working together to create even more opportunities to deliver quality storytelling to our customers." The Wall Street Journal reported that even though the U.S. regulators' deadline has passed, the Federal Trade Commission can still challenge the acquisition if a majority of the commission votes for it. Notably, the FTC is chaired by Lina Khan a critic of giant tech companies and someone whom Amazon sought the recusal of during the review. The FTC is made up of five members and split along party lines between four of them. The fifth spot is vacant. By

Local media outlets reportedthat the ships were seized off Freeport about 9 p.m. Friday. No passengers were on board when the ships were seized. The vessels are in the custody of the admiralty marshal, said Stephen Turnquest, a Bahamas-based attorney for a fuel supplier that is suing Crystal Cruises. Crystal announced in January that it would suspend ocean cruises through the end of April after Genting Hong Kong, its parent company, filedin Bermuda to dissolve the company on Jan. 18. Story continues below advertisement Last month, a federal judge in Miami issued an arrest warrant for Crystal Symphony after a lawsuit alleged Crystal Cruises and a related operator had failed to pay fuel bills reaching about $3.4 million. Instead of returning to Miami as scheduled after a two-week voyage, the vessel high-tailed it to Bimini with about 700 crew and guests on board. Crystal Cruises forced to reroute another ship: They just screwed everyone over A little more than a week later, Crystal Serenity skipped Aruba, where its aborted world cruise was scheduled to end, and also headed to Bimini. The cruise line said the port in Aruba would not let it dock. In both cases, passengers were transported to Fort Lauderdale by ferry. Advertisement The fuel supplier, Peninsula Petroleum Far East, then sued the cruise company in the Bahamas, Turnquest said. Story continues below advertisement Whether the ships are going to Aruba or anywhere else, they would have presumably taken the same approach, he said. Turnquest said the ships owners have 14 days from the date of the ships arrest to contest the proceedings. In the meantime, he said the cruise company still has the responsibility to maintain the ships and crew. He said the best-case scenario would seem to be for the company to arrange financing, pay off its debt and regain control of the ships. A cruise line hadnt paid its bills. It diverted 700 people to the Bahamas to evade capture. From a business standpoint, I would have thought that the ship owners would hasten to secure their release so that it doesnt become a fire sale proposition, Turnquest said. Quoting the acting port controller, the Nassau Guardian reportedthat nonessential crew members were being sent back to their home countries. The Washington Post could not reach the port official Monday. Advertisement Story continues below advertisement Crystal Cruises spokesman Vance Gulliksen said the company could not comment on pending legal matters. He did not provide details on what the next steps would be for crew members. The officers and crew on board are being well cared for and staying in single accommodations some of which are guest staterooms, he said in a statement. We are making sure they are comfortable and able to enjoy the various amenities on board. Crew members have been paid all wages due and we are meeting and exceeding all contractual obligations. More cruise news

, Jan. 27, 2022 /PRNewswire/ -- The "U.S. Healthcare Staffing Market Size, Share & Trends Analysis Report by Type (Travel Nurse Staffing, Locum Tenens Staffing, Allied Healthcare Staffing, Per Diem Nurse Staffing ), and Segment Forecasts, 2021-2028"report has been added to ResearchAndMarkets.com's The U.S. healthcare staffing market size is expected to reach USD 31.1 billion by 2028. It is expected to expand at a CAGR of 3.71% from 2021 to 2028. The increasing geriatric population is leading to rising demand for medical services and a shortage of nurses and other medical staff. The cost-effectivity of temporary staffing is likely to drive the market in the coming years. The geriatric population in the U.S. is gradually increasing. According to the National Institutes of Health, the number of people aged 65 years and above in the U.S. is projected to nearly double from 48 million to 88 million by 2050. This rising geriatric population is anticipated to increase the burden on the current medical workforce, creating a gap between the demand and supply of medical professionals. According to the Bureau of Labor Statistics (BLS), around 500,000 nurses will retire over the next few years. Additionally, according to the Association of American Medical Colleges, there will be a shortage of around 21,000 to 55,200 primary care doctors by 2032. A shortage of physicians in the coming years is likely to drive the market. In addition, an increasing need for a home care workforce, such as dieticians, nutritionists, nurses, therapists, and home care aides, is expected to boost the market growth. Technological advancements are driving healthcare employment. With the advent of various innovations, such as telehealth and medical informatics, the need for skilled labor to handle both technical and non-technical aspects of these devices has increased. Hence, recruitment of new professionals along with training of existing ones has become essential. The flexibility in work timings and attractive wages are primary reasons for increasing the number of nurses becoming per diem and travel nurses. Furthermore, the rising number of medical facilities and new construction projects are anticipated to create more jobs for medical professionals. For example, in April 2021 , the U.S. Department of Health and Human Services (HHS) announced USD 1 Bn to support health centers' construction and renovation projects from the American Rescue Plan. The aforementioned factors are anticipated to propel market growth. During the COVID-19 pandemic, demand for staffing services and workforce technology solutions increased dramatically. The increasing incidence of COVID-19 infection significantly fueled the demand for travel and per diem nurses. According to a poll conducted by Avant Healthcare Professionals, 90% of the medical facilities accepted using travel nurses for the management of COVID-19 patients in 2020, compared to less than 60% in 2019. On the other hand, the demand for locum tenens specialists and allied health professionals decreased due to the cancellation of elective surgeries. U.S. Healthcare Staffing Market Report Highlights The travel nurse staffing type segment dominated the market in 2020. High demand for nurses during flu seasons, travel opportunities, and nurse shortage is expected to drive the segment. For instance, the U.S. Bureau of Labor Statistics (BLS), there will be a need for over 1.1 million new registered nurses by 2022 The locum tenens staffing type segment is anticipated to witness the highest growth over the forecast period owing to the cost-effectiveness of hiring temporary employees and an increase in the trend of physicians opting for becoming locum tenens According to Staff Care's 2020 Survey of Temporary, Physician Staffing Trends report estimates that around 85% of the U.S. medical groups, hospitals, and medical facilities used locum tenens in 2019 Mergers, collaborations, and acquisitions are the key strategies undertaken by the players to improve their market position. In November 2019 , HNI Healthcare, Inc. acquired Martin Healthcare Group, a private company working across Florida and the Midwest, to expand its reach in the Midwest region of the U.S. Companies Mentioned

GDPR OneOncology Launches OneR, a Community Oncology Research Network OneOncology Research Network Will Enhance Practices' High-Quality Clinical Trials Programs While Improving Patients' Access to Innovative Oncology Therapies News provided by Oct 19, 2020, 06:01 ET Share this article , Oct. 19, 2020 /PRNewswire/ -- OneOncology, the partnership of independent oncology practices, today announced the formation of a separate subsidiary, the OneOncology Research Network (OneR). OneR is a national non-exclusive clinical trial site management organization (SMO) that will enhance the current high-performing research programs underway at participating community oncology practices by providing operational, regulatory and research support services to more efficiently execute multi-center clinical trials. OneR is a national non-exclusive clinical trial site management organization that will enhance the current high-performing research programs underway at participating community oncology practices by providing operational, regulatory and research support services to more efficiently execute multi-center clinical trials. "OneR will not only improve patient access to cutting-edge care, it will also help to advance scientific discovery." Tweet this Since clinical trials are increasingly integral to the standard of care for precision oncology, the OneR platform will expand community practices' access to more innovative therapies for their patients. At the same time, OneR provides clinical trial sponsors access to the large and diverse populations of patients who are treated in community centers throughout their cancer journey, and not episodic as is more common in research-based academic centers. With a majority of cancer care being delivered in community-based centers, OneR ensures diversity in clinical trial participation including ethnicity, gender, geography, disease status, socioeconomics and various other dimensions. "OneR is a community oncology network designed for and built by community oncology practices," said Lee Schwartzberg , MD, Chief Medical Officer, OneOncology and Medical Director, West Cancer Center. "Our north star is improving the lives of everyone with cancer which is fundamentally dependent on advancing the science of oncology treatments. We look forward to working with practices and sponsors who want to expand diverse patient access to precision oncology and other high-quality cancer clinical trials through our portfolio of therapeutic and observational studies." OneR's focus on precision oncology will offer clinical trials across tumor types with innovative trial designs based on precision oncology to oncology practices within the network like basket and umbrella trials. A basket trial tests how well a new drug works in patients who have different types of cancer that all have the same mutation or biomarker. In umbrella trials, patients with one specific cancer receive treatment based on the molecular profile of their individual cancer. "With too many of our patients disproportionately impacted by health disparities, we believe that by providing community oncology practices with enhanced operational efficiencies we can ensure that more patients will benefit from the groundbreaking clinical trials," said Axel Grothey , MD, Medical Director, OneR and Director, GI Cancer Research, West Cancer Center. "OneR will not only improve patient access to cutting-edge care, it will also help to advance scientific discovery." As oncology practices invest in their clinical trial infrastructure and conduct more trials, OneR's efforts will enhance a practice's ability to increase clinical trial participation, by centralizing business functions, regulatory submissions and clinical trial matching technology while also ensuring practices maintain their flexibility to participate in other clinical trial initiatives. OneOncology's technology platform and collaboration throughout the network allows for seamless clinical trial management across all of its research sites. As a non-exclusive SMO, practices are not limited to only participate in OneR clinical trial programs. OneR will be co-headquartered in Nashville

, making the membership more accessible and inclusive than ever before. At just $19.99 per month, the cost of a Vital Care membership pays for itself when unlocking the best of Petco through exclusive savings on nutrition, grooming, litter, routine veterinary exams and more. "Over the last two years, families around the country have welcomed millions of new pets into their homes, and with inflation impacting all Americans' everyday lives, our innovative Vital Care program is fundamentally changing the way people care for their pets' health and wellness while keeping their wallet healthy, too," said Jenny Wolski Senior Vice President of Omnichannel Experience at Petco. "Caring for our pets shouldn't be complicated or break the bank. With benefits valued between $320 and $404 per year, plus helpful resources every step of the way, the plan saves pet parents both time and money. If our pets could do the math, we think they'd agree - Vital Care is just smart Petconomics!" Launched in , Vital Care originated as part of Petco's commitment to supporting the overall health and wellness of pets. Today, with nearly 160,000 pets enrolled, Petco has enhanced the program to include even more benefits for dogs and a new plan tailored for cats. At $19.99 per month with an annual commitment, the cost of Vital Care can be offset by what members get in return, including: $15 Pals Rewards every month to use on any health and wellness needs they may have $20 Pals Rewards for every routine exam at the vet of your choice or unlimited routine exams at participating Petco vet locations 20% off full-service grooming for dogs* 20% off all litter for cats 10% off all nutrition** An additional 5% off nutrition and litter when used with Repeat Delivery $20 off pet boarding, dog walking, or pet sitting services on Rover.com, coming soon To educate pet parents on new Vital Care benefits and tap into the realities of the current inflationary environment, Petco launched " Petconomics, " a dedicated marketing campaign that highlights the membership's "Great Dane-sized" benefits at a "Chihuahua-sized" price. Featuring economics-inspired creative "Petconomics" highlights the win-win that Vital Care presents to pet parents: a healthy pet and a healthy wallet. Beyond annual savings, the "Petconomics" concept also showcases how Vital Care is a convenient and affordable gateway to investing in long term routine care that can help pet parents keep their pets happy and healthy while reinforcing Petco's commitment to providing accessible pet healthcare. "With personal finances top of mind for everyone right now, clearly and cleverly illustrating the smart 'Petconomics' of a Vital Care membership for pet parents is foundational to our role as their partner in pet health and wellness," said Katie Nauman Chief Marketing Officer at Petco. "Looking at this membership through the lens of personal finance gave us a timely and relevant way to connect with pet parents while also reinforcing the straightforward wellness and economic upsides to enrolling." Petco is also launching a Vital Care affiliate program to make the membership's routine care accessible to even more pet parents by extending exclusive Vital Care benefits and discounts to its affiliate partners' employees and customers. Beginning this spring, the affiliate program will launch with several partners, including Rover.com, the San Diego Padres, Companion Protect, Central Garden & Pet, and more. In addition to the business-to-business focus, Petco has teamed up with Hill's Pet Nutrition, which supports shelters through its Food, Shelter & Love program, to offer exclusive Vital Care benefits and discounts to shelters across the country with the goal to provide post-adoption support and ensure adopted pets stay in their loving homes. Jacksonville Humane Society, Oklahoma Humane Society, Brandywine SPCA, Baltimore Animal Rescue & Care Shelter, and Friends of Pima Animal Care Center are each signed on to launch Petco's Vital Care Shelter Affiliate program. If you and your business are interested in participating in Petco's Vital Care Shelter Affiliate program, please reach out to us at [emailprotected] Enhanced Vital Care benefits are available now to new and existing members and can be used in-store, online or in the Petco app. To learn more about Vital Care , visit petco.com/VitalCare *Full-service baths include deep-cleaning shampoo, blow-dry, 15-minute brushout, scented spritz, gland expression, nail trim and ear cleaning. Full-service haircuts include breed-specific cut and style, deep cleaning shampoo, blow-dry, 15-minute brushout, scented spritz, gland expression, nail trim and ear cleaning. Full-service grooming includes breed-specific cut and style, deep-cleaning shampoo, blow-dry, 15-minute brushout, scented spritz, gland expression, nail trim and ear cleaning." Grooming services for dogs only. **Nutrition savings does not include treats and chews. Grooming services for dogs only. About Petco, The Health + Wellness Co. Petco is a category-defining health and wellness company focused on improving the lives of pets, pet parents and our own Petco partners. Since our founding in 1965, we've been striving to set new standards in pet care, delivering comprehensive wellness solutions through our products and services, and creating communities that deepen the pet-pet parent bond. We operate more than 1,500 Petco locations across the U.S., Mexico and Puerto Rico, including a growing network of more than 150 in-store veterinary hospitals, and offer a complete online resource for pet health and wellness at

Taylor counties. "The collaboration between Flint Energies and Conexon offers multiple advantages," Conexon Partner and Conexon Connect CEO Randy Klindt said. "The state-of-the-art infrastructure improvements that smart grid delivers will provide Flint with operational efficiencies and benefits, while the Connect partnership gives Flint Energies an opportunity to assist in meeting the broadband needs of unserved and underserved members. We're proud to be part of another Georgia project and look forward to working with the Flint team." Flint's nearly $90 million fiber network is expected to be completed within four years. The lightning-fast fiber-optic network will offer members access to symmetrical (same upload and download speeds) gigabit internet capabilities among the fastest and most robust in the nation. Additionally, it will provide reliable, clear phone service. "Flint is strengthening its overall electric system through a fiber backbone that gives us smart grid operational benefits that will enhance our ability to continue offering exceptional service to members," Flint Energies CEO Jeremy Nelms said. "That initiative allows us to also meet the pressing needs of our unserved and underserved members for high-speed internet. We believe the time for us to act is now, and we're thrilled to have found partners like Conexon and Conexon Connect to make this happen." Conexon and Conexon Connect work with electric cooperatives committed to serving their members with fiber broadband. With its clients, the company has designed more than 200,000 miles of fiber, builds more than 50,000 miles of fiber annually, and has connected more than 500,000 rural Americans to fiber to the home. About Conexon Connect Conexon Connect is the internet service provider (ISP) arm of rural fiber broadband design and construction management leader Conexon. The subsidiary was formed to operate and manage cooperative fiber-to-the-home networks. Connect leverages Conexon's decades of co-op operations, fiber-optic design and construction, telecommunications, federal and state lobbying and customer experience management expertise to successfully launch and operate projects. The Connect approach is to work with electric cooperatives to launch and deploy high-speed fiber-optic networks the gold standard of communications transmission enabling them to offer world-class fiber broadband to their members. In partnership with Georgia EMCs, Connect will deliver fiber internet access to approximately 188,400 rural homes and businesses across the state. About Conexon Conexon works with Rural Electric Cooperatives to bring fiber to the home in rural communities. The company is comprised of professionals who have worked in electric cooperatives and the telecommunications industry, and offer decades of individual experience in business planning, building networks, marketing and selling telecommunications. Conexon offers its electric cooperative clients end-to-end broadband deployment and operations support, from a project's conception all the way through to its long-term sustainability. It works with clients to analyze economic feasibility, secure financing, design the network, manage construction, provide operational support, optimize business performance and determine optimal partnerships. To date, Conexon has assisted more than 200 electric cooperatives, 60 of which are deploying fiber networks, with more than 500,000 rural Americans connected to fiber to the home. The company has secured nearly $2 billion in federal, state and local grants and subsidies for its clients. Cindy Parks

Published 28 March 2022 GRICD, a cold chain technology company that uses the Internet of Things to enable last-mile delivery of temperature-sensitive products, has partnered with Haultrac, a logistics company, to improve the delivery of essential healthcare commodities to all 36 states of the nation, as well as the Federal Capital Territory, Abuja on behalf of USAID. According to the firms, the healthcare commodities include medicines, rapid diagnostic test kits, laboratory reagents, and consumables. In a statement, Chief Executive Officer and founder of Gricd, Oghenetega Iortim, said, Inability to keep temperature-sensitive medical commodities within required temperature range leads to waste of life-saving medication, sometimes loss of life. We are excited to be working with Haultrac and USAID to ensure the safe delivery of these essential commodities across Nigeria and make it easier for all parties to do business with confidence. The CEO of Haultrac, Segun Adeoye, added, Transporting temperature-sensitive commodities over long distances in a country like Nigeria can present many challenges. However, with real-time monitoring, we can move these commodities with confidence and take proactive steps to reduce wastage and maximise the value of these commodities. The firms said, Using Gricds Real-Time Data Loggers and Enterprise Monitoring Software, all parties will be able to guarantee the quality of these commodities during storage, transit, and distribution to the end-user. Read Also

UK's Premier Foods sees annual earnings above expectations By Reuters 5 days ago (Reuters) - Premier Foods expects its full-year profits to come in above market expectations, as its trademark Mr Kipling brand delivered its best-ever Christmas sales after consumers splurged during the festive season. The company said it expects its trading profit to be at least 145 million pounds ($197.58 million) for the fiscal year ending April, ahead of analysts average estimate of 140.7 million pounds, according to a company-compiled consensus. ($1 = 0.7339 pounds)

Spectrum . Private equity firm Alpine sees an opportunity for growth in AirDNA, given that there are an estimated 4 million managers worldwide renting transiently. But it also sees an opportunity for growth in applying the companys data solutions to other industries, such as hotels and real estate. Anticipating that, Demi Horvat joins as chief operating officer. Business Intelligence for Short-Term Rentals AirDNA helps customers put any given propertys performance in context, similar to what companies such as CoStars STR [Smith Travel Research ] and Kalibri Labsdo for hotels. But unlike companies like STR in the hotel space, not all of these analytics companies get supplementary live data feeds from suppliers. Resellers such as Airbnb have said that external vendors arent able to provide fully accurate business intelligence because of faulty assumptions and errors. AirDNA and its peers often rely a lot on ingesting publicly displayed inventory and availability to generate their analytics. Yet the analytic services of AirDNA and some of its rivals, such as Transparent Alltherooms Airbtics KeyData Mashvisor have good enough data quality sometimes through direct data feeds that customers keep paying. The startups help analysts optimize their benchmarks for performance. AirDNA, for example, has offered dashboards, benchmarks, and reports for the short-term rental sector. But it aims to be more than a data provider. Our suite of solutions help you answer questions like how to acquire supply, which could involve getting a management contract, and how to figure out your revenue management strategy once you have the supply, Shatford said. Were able to deliver an estimate on a property and price it for the next year by looking at how similar properties in the neighborhood are performing. For investors in public companies such as Airbnb, Sonder, and Vacasa, AirDNA also offers analytical solutions. Its answering customer questions like, how do you know what good performance looks like, such as how well were you performing a year ago versus next years forecast,' Shatford said. How can I better communicate what good looks like to owners and managers?' May 11-12, 2022

Send email HCAOA elects new board president The Home Care Association of America (HCAOA) has elected Emma Dickison as the new president of its board of directors. Washington, D.C.-based HCAOA represents nearly 3,000 companies that employ more than 500,000 caregivers. Dickison brings her background as CEO of Home Helpers Home Care a company shes been with since 2007 to the role. Advertisement Throughout her career, Emma has been an innovative leader who provides a laser focus on the most important aspects of her business, Peter Ross, outgoing president of the HCAOA board of directors, said in a press release. Her track record of exponential growth and expert knowledge of the industry perfectly aligns with our desire to reach the next level. Home Helpers was in 2016. During her time at Home Helpers Home Care, Dickison has doubled the home care franchise from about 500 communities to over 1,000. The home care space is very dynamic and it is changing, . We have been, I believe, a leader in those changes. Not just in franchising, but in home care. Our average growth rate over the last three years was 24%. Weve outpaced the industry in that regard. Dickison has served on HCAOAs board of directors since 2015. Humana snags CMSs CMO Humana Inc. (NYSE: HUM) has poached one of the Centers for Medicare & Medicaid Services (CMSs) key leaders. Popular Reports

10:29 PM CST February 7, 2022 Updated: 10:49 PM CST February 7, 2022 LITTLE ROCK, Ark. You've probably seen advertisements offering you a cheaper way to straighten your teeth and do it all at home without visiting a dentist in person. Sounds like a great alternative, right? Well, professionals are now warning that doing this could come at a cost to your wallet and your health. If you've been looking for an inexpensive way to straighten your teeth, you've probably considered some online companies. They are marketed as an affordable option and allow you to do it from the convenience of your own home. This DIY method may help you cut costs but it doesn't include a professional orthodontist who can provide certified treatment, and that's what dentists say is most important. Dr. D.J. Dailey of Smile Dailey in Little Rock said he has seen his share of patients who have tried these online aligners. Overall I would say the reviews that have been reported to me are that people have had problems with them," he said. A YouTuber who went through with online aligners said, "Now that I'm all finished, that part is still crooked. I'm paying a good chunk of money to have straight teeth and they're not as straight as I thought they were going to be." Now dental professionals are alerting patients of the dangers that could come along with using these at-home kits. The American Association of Orthodontists (AAO) issued a consumer alertthat warns people that direct-to-consumer orthodontic companies do not involve in-person evaluation or supervision of your orthodontic treatment. According to the AAO, it "could lead to potentially irreversible and expensive damage such as tooth and gum loss, changed bites, and other issues if not done correctly." "If you have some type of underlying dental health issues that have gone unfound or undiagnosed particularly like gum disease or periodontal disease as we call it if there is a gum condition that's existing and you go to move the teeth and it can actually make it worse. It can accelerate it," Dr. Dailey explained. We reached out to a couple of these companies inquiring about their procedures. In a statement, Smile Direct Club, a company that offers the at-home aligners, said, "Smile Direct Clubs innovative telehealth platform for orthodontia connects state-licensed dentists and orthodontists with patients using the same technology that has been widely embraced by other medical categories such as general medicine and dermatology, making premium teeth straightening more accessible, affordable, and convenient for more people. While some may have misconceptions about how Smile Direct Club's network of doctors has used telehealth to successfully treat more than 1.5 million orthodontic patients worldwide, we welcome them to educate themselves on how we have pioneered this field of oral care treatment." Dr. Dailey said bottom-line, do your research. Before you make any decision about orthodontic treatment, you may want to consider an in-person consultation with a certified dental professional. "I certainly wouldn't look badly upon anybody who wants to try to save money and straighten their teeth, I totally get that. But at the same time, it's your body you're talking about," Dr. Dailey said. "It's not just some random thing that you're trying to accomplish. It's your body and this should be with you your entire life," he said. If you are considering teeth straightening treatment, the AAO has answers to a list of questionsyou should ask before choosing your method of treatment. Related Articles

Share to Linkedin Immersive technology overview refers to technology that enhances reality by blending the physical environment with the virtual environment. There are various immersive technologies; augmented reality (AR), virtual reality (VR), mixed reality (MR), and virtual worlds (VW). Many companies in several industries have adopted and embraced immersive technology since it has become more affordable and user-friendly. It won't be long before this technology is pervasive and ubiquitous across industries and consumers. Although early adopters were from the gaming industry, now immersive technologies have become part of many industries, including healthcare and well-being. This technology is available anywhere, at any time. It also democratizes care for vulnerable populations and creates a new solution for physical and psychological health and loneliness through social reality. It is important to note that immersive technology has roots as far back as the 1950s. The timeline below illustrates the development of immersive technologies over time and provides a helpful frame in understanding the present and future of this technology. Immersive Technology Timeline by Vista Partners & Bernard Marr 1957-1991: Morton Heilig was the man who made a working VR machine in 1957. Wind, scent, vibration - Mortan had everything but success. However, in 1968, The Sword of Damocles was the first VR head-mounted display connected to a computer rather than a camera. It is the blueprint for VR headsets seen today. 1991: Sega launched the Sega VR headset for arcades and home use at the Consumer Electronics Show. However, only the arcade version was released due to technical difficulties. 19921999: The development of AR picked up when Louis Rosenberg created Virtual Fixtures, the first fully-immersive AR system for the U.S. Air Force. Sportvision developed the virtual yellow line so that NFL viewers could see the line of scrimmage and first downline while watching football games on television. 1999: Hirokazu Kato developed the ARToolKit, an open-source library for the development of AR applications. 2009: Esquires magazine cover starring Robert Downey Jr. provided additional content to consumers through a QR code on the cover. 2012: the world changed when Oculus launched Rift in a Kickstarter campaign. and began releasing pre-production models to their developers. 2013: Google started selling a prototype of Google Glass, which became available to the public in 2014. 2014: Facebook purchased Oculus for $2 billion, demonstrating a growing market interest in VR. 2015: Google Glass stopped production 2015. 2016: Microsoft joined the game with the release of its HoloLens headset, which took the idea of AR to a new level by creating a more interactive experience (hence, the phrase "mixed reality"). This was also when the Pokmon GO game bought AR into the mainstream. Pokmon GO brought AR gaming to a mass audience. The game was one of the most used and downloaded apps in App Store history, with over 500 downloads by the end of 2016. By 2020: VR, AR, and MR had quickly extended to various industries. Today, the adoption of all these technologies (Extended Reality, XR) are across all sectors as diverse as manufacturing, education, construction, law enforcement, and even healthcare. Recent Developments In Immersive Technologies A success in the industry, Charlie Fink, wrote about the Bleeding edge of VR & Healthcare in May 2017 promoting the first Virtual Reality and Healthcare Symposium. The focus was on the impact of virtual reality on health and medicine at George Washington University. Three years later (2019), one of the most influential organizations in the industry was founded by Bob Fine, The International Virtual Reality and Healthcare Association (IVRHA). The IVRHA is a member-driven organization comprised of entities throughout the healthcare ecosystem, including technology companies, teaching hospitals and universities, healthcare providers, and insurance companies. The IVRHAs mission is to facilitate and support the growth of virtual reality in the health and life sciences. In March 2022, the IVRHA engaged in a gathering of the original visionaries, current company game changers, and newbies, who were all excited to be part of the 6th Annual Virtual Reality and Healthcare Symposium hosted at Vanderbilt University in Nashville, Tennessee. The conference was focused on providing unique content perspectives from across the global healthcare and well-being spectrum. There was also a focus on new emerging voices from across the ecosystem: care, technology, research, and policy. MORE FOR YOU Immigrants Hope Registry Saves Immigration Bill Speakers The conference keynote was Walter Greenleaf, a neuroscientist and medical technology developer at Stanford University. Walter is considered a leading authority in digital medicine and medical virtual reality technology. Walter inspired hundreds of people in the audience. He shared his latest research on developing computer-supported clinical products, with a specific emphasis on applying virtual reality and digital health technology to address complex problems in behavioral and physical medicine such as Post-traumatic Stress, Anxiety Disorders, Depression, Stroke, Addiction, and Autism Spectrum Disorder. His latest presentation was at the 2022 SXSW, VR & Brain Health: a Neurotech Frontier for Aging. Game-changer Dr. Skip Rizzo, a top researcher in the Clinical VR space and Director of Medical Virtual Reality at USC's Institute for Creative Technologies, presented his latest research, A Model for the Integration of Virtual Reality with Psychedelic Enhanced Therapy. He spoke about how the combination of Immersive Experience with the equally powerful ability of psychedelics to promote neuroplasticity (reprogramming neural pathways in the brain). The research shows promising treatment options for cognitive, psychological, motor, and functional impairments across various clinical health conditions. Nanae Reaves , a trailblazer in tech, spoke about her company, TRIPP. She describes it as the fitness solution for your inner self. The design of the TRIPP experience leverages a large body of existing research on the use of technology in the mental wellness arena. It utilizes proven mindfulness structures, targeted sound frequencies, visuals, and interactions that have a multiplicative effect when administered through VR immersion. In 2022, Tripp won Best VR Meditation of the year. Tune in next week for Part 2 to learn more about social virtual worlds increasing well-being at the workplace with ImmersiveWorlds. Find out about moving from gamer to patient with Penumbra. Discover Viva Vita with a VR solution to make aging more engaging. And a sneak peek of what Meta is working on with this innovative technology for employee well-being. Follow me on

, Sheffield, Uk UPDATED ON JUL 30, 2021 08:03 PM IST Vitamin D supplements are not an effective treatment for easing painful symptoms of Irritable Bowel Syndrome (IBS), a new study from the University of Sheffield revealed. The findings of the study appeared in the European Journal of Nutrition. Scientists from the University's Department of Oncology and Metabolism - in conjunction with a health supplement company, BetterYou - carried out trials on participants who suffer from the chronic condition of the digestive system to assess whether vitamin D reduced the severity of their symptoms and whether it could improve their quality of life. Results of the study found that despite an improvement in vitamin D status in the participants in response to a vitamin D3 oral spray supplementation over a 12-week trial, there was no difference to their IBS symptom severity over the same period, nor a reported change in the participants' quality of life. IBS is a common functional bowel disorder, characterised by chronically relapsing perturbed bowel habit. It causes symptoms such as stomach cramps, bloating, diarrhoea and constipation. For some, symptoms will come and go, but for others, it can severely affect their quality of life, often causing embarrassment leading to many living with the condition undiagnosed, affecting both mental health and wellbeing. Carried out in collaboration with Sheffield Teaching Hospitals NHS Foundation Trust, the study also identified that although vitamin D supplements do not ease symptoms of IBS, a vitamin D deficiency is widespread amongst the IBS population, potentially leading to an increased risk of suffering from fractures and osteoporosis in the long-term. Co-author of the study Dr Liz Williams, a Senior Lecturer in Human Nutrition at the University of Sheffield, said: "There has been interest from researchers and from patient groups in the potential of high dose vitamin D to alleviate symptoms of IBS, but there haven't been many properly controlled trials in this area. What our research shows is that supplementing vitamin D at a safe dose did not reduce the severity of IBS symptoms." "It is worth noting, however, that the vitamin D supplementation did correct deficiencies in those people who were found to have poor vitamin D status, and this is important for other aspects such as bone and muscle health," added Dr Williams. Lead-author Professor of Human Nutrition and Health at Newcastle University and Honorary Fellow at the University of Sheffield, Bernard Corfe, said: "For some people living with severe IBS, low vitamin D levels may be attributable to changes in diet and lifestyle. Some may feel due to the severity of their symptoms that they limit their outdoor activities due to the anxiety their symptoms can cause, or alter their diet to avoid certain foods triggering their symptoms." "Unfortunately all of these coping mechanisms can be detrimental to overall health and wellbeing and reduce exposure to valuable sources of vitamin D. Given that vitamin D is essential for overall health and wellbeing, it is still important people with IBS get tested and treated and seek dietary advice so it does not impact on their long term health," added Corfe. The research team at Sheffield were the first to suggest a possible link between people living with IBS and low vitamin D levels in 2012, and have since followed the issue closely. The study is the largest, and most definitive study to date showing clearly that vitamin D supplementation does not ease severe IBS symptoms. Although little is known about why and how the debilitating condition develops, and there is currently no cure for IBS, further research is trying to identify better ways to support and manage people living with the chronic condition. Professor Corfe added, "There is a range of management strategies that people living with IBS can seek help with from their GP, but because of the heterogeneity of the syndrome, managing IBS can be trial and error for each individual patient." "As it is estimated that between five and 15 per cent of the population could be living with IBS - some undiagnosed due to the anxiety and embarrassment their symptoms can cause - it is vitally important we continue with research to find new ways to diagnose, treat and understand the impact of IBS on the population," concluded Professor Corfe. This story has been published from a wire agency feed without modifications to the text. Only the headline has been changed. SHARE THIS ARTICLE ON

Job Description Are you looking for an exciting role that is fun, diverse and rewarding every day? Creative Support is looking for a warm, dedicated and caring Support Workers to join our friendly staff team in Quorn, Leicestershire. Here we provide quality care and support to a number of residents, helping and encouraging them to lead a fulfilling and enriched life. At this vibrant service in Quorn, we support individuals with a range of support needs, including learning disabilities and complex needs. The individuals at this service love to engage in a wide range of activities such as watching Leicester Tigers RFC, visiting sensory rooms, swimming and visiting local shops and cafes whilst providing direct support to engage in these. As a Support Worker, you will need to be enthusiastic about communicating with and supporting people in a person centred manner. Working alongside our dedicated team you will provide personal, practical, emotional and social support to individuals with learning disabilities who have limited communication, enabling them to have a great quality of life as important and valued members of the local Quorn community. Your role will include: Providing respectful personal care and administering medication Encouraging residents to engage in a range of exciting social activities both within and outside the home Developing warm and trusting relationships with service users enabling them to enjoy their time at the service to the fullest Work flexibly on a rota according to the needs of the service, including evenings and weekends No previous care experience is needed as full training is provided by our Creative Support Training Academy, as is the opportunity to work towards QCF Diploma in Health and Social Care. Benefits of working with Creative Support: A one-off bonus of 100 upon successful completion of the 4-month probationary period. Competitive pay and a pension with company contribution and 28 days annual leave, Company paid enhanced DBS for all staff Free employee support programme All our staff are supported 24/7 by our out-of-hours teams Support to complete the nationally recognised Care Certificate and Social Care Diploma Creative Support is a passionate, inclusive, and anti-racist organisation. We are a Stonewall Diversity Champion, Disability Confident Employer who have recently received Investors in People Silver award. We actively encourage applications from candidates from all backgrounds and cultures. We would encourage you to apply to us even if you have not yet had your COVID 19 vaccine. You will be required to have your first COVID 19 vaccine prior to your interview and your second vaccine before you start work with us. This time will be used to complete post interview recruitment checks.

Utah nonprofit drugmaker says it can make 1/3 of Americas insulin and sell it cheap Lehi-based Civica Rx says its new insulin line could reshape drug pricing nationwide. (Rachel Rydalch | The Salt Lake Tribune) Katherine Stewart, from Highland, Utah, holds up an emergency nasal powder called BAQSIMI, that she has to use if her blood sugar goes too low, Tuesday, March 8, 2022. By Erin Alberty | March 8, 2022, 10:37 p.m. A Utah-based nonprofit drug company plans to introduce generic versions of costly insulin, potentially revolutionizing drug pricing schemes that have long been considered predatory and financially excruciating for diabetics. Our goal is to democratize insulin, said Dan Liljenquist, board chair of Civica Rx and chief strategy officer for Intermountain Healthcare. These insulin molecules are well past their patented life, and were intending to produce these insulins so that these formulas, which are owned by society, enter the public domain within reach of regular people. Civica Rx will make generic versions of Humalog, Novolog and Lantus at $30 per vial or $55 per five-pack of injectable pens a price reduction of 80% to 90% compared to the brand-name drugs, Lilienquist said. Pending licensure by the Food and Drug Administration, the insulin will be manufactured at a 3.2-acre factory in Petersburg, Va., where Civica expects to be able to produce 80 million vials and 50 million pens each year about a third of the insulin prescribed in the United States, Liljenquist said. Thats enough to potentially change how insulin is priced, he said. Insulin is so expensive, its something Ive already started to worry about, said Katherine Stewart, 16, of Highland. Stewarts family has spent about $500 a month on insulin since she was diagnosed with diabetes at age 5 and thats for the months after the family has met its insurance deductible. Until then, the cost is closer to $2,000. Having to worry about this seems like growing up too fast, Stewart said in a news conference Tuesday. The familys costs declined after lawmakers capped insulin copays in 2020 , but those caps only apply to patients with group insurance plans. Meanwhile, many Utahns are rationing insulin, which can be deadly for diabetics, and begging online for leftover doses Social media companies have cracked down on Utahs not-so-secret underground insulin trade, which is technically illegal, so now desperate patients and their families have begun to encode their pleas with spelling errors and alternate wording to evade bots, said Brandi Stewart, Katherines mother. Meeting other Utah families coping with insulin costs over the years has shown her that $500 a month is not the worst of it, she said. Another family that had three diabetic children paid $11,000 in one month out of pocket for their three kids insulin because it was the first of the year and their high deductible had not been met yet, Brandi Stewart said. Thats a huge financial burden that a lot of Utahns just cant afford, and it doesnt need to be that way. The lack of transparency in prescription drug prices has made it difficult to know who exactly ends up with all of that money. Insurers point to pharmacy benefit managers middlemen that negotiate with pharmaceutical companies to decide which drugs an insurer will cover. When a PBM lists a drug for insurance coverage, they get a rebate from the drug company, which the PBMs say they pass along to the insurance company to reduce premiums. But no one knows how much of that rebate gets passed on to the insurer, or whether the insurer actually uses it to reduce premiums and just three PBMs control about 80% of the U.S. market Industry watchdogs have worried that these rebates give PBMs an incentive not to include cheaper drugs on insurance plans, since those capture smaller rebates than expensive drugs do. That pricing mechanism may also explain why generic insulin has been slow to catch on. Months after Eli Lilly introduced a generic version of Humalog in 2019, only 1 in 5 Americans with commercial insurance were on plans that covered it. In a phone survey conducted by U.S. Senate staffers, 83% of the pharmacies they called didnt even have the generic version in stock and 69% said they couldnt even order it. And two months after Novo Nordisk introduced a generic version of Novolog in 2020, its uptake was even slower, according to GoodRx.com But there are a few reasons Civicas generics may take off, even where for-profit drug companies own generics did not. First of all, Civica is nonprofit and is not producing generics that will compete with its own, pricier brand-name products, as for-profit companies have. That means it has no incentive to downplay the generic in marketing. When youre making a more-expensive insulin on the same production line as the less-expensive insulin, whats in your interest to sell? Liljenquist asked. Second, Civica has lined up insurers, including SelectHealth, Blue Cross Blue Shield Association, Kaiser Permanente and Anthem, Inc. as partners. We dont think the pharmacy benefit managers or other people could block this, Liljenquist said. Third, even if no insurers were willing to cover Civicas insulin the prices still are a fraction of the out-of-pocket costs for millions of patients who dont live in the 20 or so states that have passed insulin caps, or who are either uninsured or covered by self-funded plans, which arent subject to state copay caps. (A national insulin cap, while popular, has met with challenges in Congress) How are you going to persuade a family to go and shell out thousands of dollars they cant afford for insulin, to stay in-benefit when they can go to an online pharmacy and get Civica insulin at a fair price? Liljenquist said. It will unstick the rebate game for insulin, and thats exactly what we intend to do, so that the patients who are the ones paying the cost of those rebates actually get to pay a fair price upfront. Civica expects to complete building its Virginia plant by the end of the year and launch its insulin line in 2024, Liljenquist said. When theres a market failure like this, that is exploitive, that takes advantage of people who already desperately trying to manage disease, its wrong, he said.

Share The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says 'The biggest investment risk is not the volatility of prices, but whether you will suffer a permanent loss of capital.' When we think about how risky a company is, we always like to look at its use of debt, since debt overload can lead to ruin. As with many other companies Besunyen Holdings Company Limited ( ) makes use of debt. But is this debt a concern to shareholders? When Is Debt A Problem? Generally speaking, debt only becomes a real problem when a company can't easily pay it off, either by raising capital or with its own cash flow. In the worst case scenario, a company can go bankrupt if it cannot pay its creditors. While that is not too common, we often do see indebted companies permanently diluting shareholders because lenders force them to raise capital at a distressed price. Of course, the upside of debt is that it often represents cheap capital, especially when it replaces dilution in a company with the ability to reinvest at high rates of return. When we examine debt levels, we first consider both cash and debt levels, together. View our latest analysis for Besunyen Holdings What Is Besunyen Holdings's Net Debt? The image below, which you can click on for greater detail, shows that at December 2018 Besunyen Holdings had debt of CN150.0m, up from CN20.0m in one year. However, because it has a cash reserve of CN94.9m, its net debt is less, at about CN55.1m. More A Look At Besunyen Holdings's Liabilities According to the last reported balance sheet, Besunyen Holdings had liabilities of CN301.2m due within 12 months, and liabilities of CN86.7m due beyond 12 months. On the other hand, it had cash of CN94.9m and CN66.1m worth of receivables due within a year. So it has liabilities totalling CN226.9m more than its cash and near-term receivables, combined. This deficit isn't so bad because Besunyen Holdings is worth CN568.3m, and thus could probably raise enough capital to shore up its balance sheet, if the need arose. However, it is still worthwhile taking a close look at its ability to pay off debt. There's no doubt that we learn most about debt from the balance sheet. But you can't view debt in total isolation; since Besunyen Holdings will need earnings to service that debt. So if you're keen to discover more about its earnings, it might be worth checking out this graph of its long term earnings trend In the last year Besunyen Holdings actually shrunk its revenue by 30%, to CN378m. To be frank that doesn't bode well. Caveat Emptor While Besunyen Holdings's falling revenue is about as heartwarming as a wet blanket, arguably its earnings before interest and tax (EBIT) loss is even less appealing. Its EBIT loss was a whopping CN137m. Considering that alongside the liabilities mentioned above does not give us much confidence that company should be using so much debt. Quite frankly we think the balance sheet is far from match-fit, although it could be improved with time. Another cause for caution is that is bled CN121m in negative free cash flow over the last twelve months. So in short it's a really risky stock. For riskier companies like Besunyen Holdings I always like to keep an eye on the long term profit and revenue trends. Fortunately, you can click to see our interactive graph of its profit, revenue, and operating cashflow When all is said and done, sometimes its easier to focus on companies that don't even need debt. Readers can access a list of growth stocks with zero net debt100% free, right now. We aim to bring you long-term focused research analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. If you spot an error that warrants correction, please contact the editor at [email protected] This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Simply Wall St has no position in the stocks mentioned. Thank you for reading.

DANBURY A Nissan-Infinity dealership that wants to take over an empty retail building near Danbury Fair mall is the latest sign that an emerging high-end auto niche is taking off on the citys west side. It was subtle a few years ago with some of these high-end automotive uses but its anything but subtle now, said P.J. Prunty, executive director of the Greater Danbury Chamber of Commerce. Prunty was speaking of an application by Bruce Bennett Nissan of Danbury to renovate the 78,000-square-foot retail building on Sugar Hollow Road that once housed Sports Authority and Bed, Bath and Beyond. The 8-acre property in question, which will be the subject of a public hearing on Tuesday, would become the latest addition to the high-end automotive market along an industrial stretch that hugs the eastern perimeter of Danbury Municipal Airport. The stretch is home to Porsche, Audi and Volkswagen dealerships, high-end auto garages such as Speedsport Tuning and Collector Car Services, luxury auto garages including a soon-to-open 50,000-square-foot storage and restoration center billed as the largest of its kind in Fairfield County, and specialty manufacturers including a film directors company that makes $450,000 sports cars. Just last month at Sugar Hollow and Miry Brook roads, Danburys wetlands commission moved plans forward by a New York car dealership to build a Mercedes-Benz sales and service center on a 2.5-acre construction materials site. It speaks volumes about Danbury as a place to locate and grow your business, and it speaks to the pro-business approach that this economy invites, Prunty said. I also tip my hat to the commercial real estate brokers who are deep in this process and contributing to the strong economic boom over there. The Nissan proposal, which already has approvals from the citys Planning Department and the citys Environmental Impact Commission, needs a certificate to sell new cars in the commercial zone from the Zoning Commission, which could come as soon as Tuesday night. The applicants attorney says the proposal fits in with the corridors future. There are other car dealerships neighboring this property, and, therefore, this site and this neighborhood are appropriate for this new Nissan car dealership, said attorney Thomas Beecher in a letter to the citys Zoning Commission. The proposal calls for refitting the retail store with a showroom, an office, a 15-bay service center, and a storage area for parts. The emergence of the high-end auto corridor is part of a larger commercial boom on Danburys west side. In addition to the redevelopment of the 1.2 million-square-foot Summit office complex on Reserve Road, a proposed 11-building complex of apartments and commerce on Mill Plain Road has been in the headlines. The city has also approved a $36 million rehabilitation hospital and an $80 million proton therapy cancer center on the west side, among other projects. These commercial real estate brokers are playing a key role in bringing these deals across the finish line, Prunty said. [email protected] 203-731-3342

SPONSORED: AMICULUM and BioDundee celebrating 20 years By Courier Commercial May 10 2021, 12.30pm Dr Richard Allcorn - Co-founder of AMICULUM 2021 is a significant year for the BioDundee International Conference and AMICULUM an independent healthcare communications agency. This years BioDundee Conference promises to be a landmark occasion; not only is this the first time the event has been hosted online, it also marks the 20th anniversary of the international conference. Since its establishment, the collaborative environment fostered by BioDundee has played an active role in strengthening relationships between the life sciences and healthcare sectors. This annual event is a valuable opportunity for thought leaders and organisations to come together, sharing knowledge and key insights from across the industry. AMICULUM is one of many organisations that have benefited from the opportunities for collaboration that the BioDundee community enables, and is delighted to support this years virtual conference. Like BioDundee, AMICULUM is celebrating its 20th birthday this year, making 2021 an important milestone for both. About AMICULUM The AMICULUM story began in 2001, when co-founders Dr Richard Allcorn and Dr Jenny Putin set out to build an independent global healthcare communications agency from scratch. The company has grown from a self-funded start-up into a global team of over 300 healthcare communications professionals who work with global pharmaceutical companies in some of the most complex and exciting areas of medicine. AMICULUM now comprises a family of specialist teams that deliver expertise in health communications, medical publications, healthcare learning, clinical and commercial consultancy, market access, rare diseases, digital engagement, and cell and gene therapies. Collaboration opportunities with BioDundee AMICULUM was planning to establish its first team in Scotland in 2018 when a meeting organised by BioDundee provided the company with an insight into the highly collaborative nature of the citys life sciences sector. Discussions with stakeholders, including the University of Dundee, Dundee City Council and Scottish Enterprise, led to the establishment of AMICULUMs office at Dundee University Incubator. The Dundee office has continued to grow and now consists of team members who specialize in medical writing, client services, and creative design. We have created opportunities for a number of University of Dundee graduates and are seeking further collaborations in the city and region. Supporting this years BioDundee conference is therefore a welcome opportunity for AMICULUM to express its thanks to the organisers for their support over the last few years as the agency continues to build its presence in the city. For more information, visit the AMICULUM website here Help support quality local journalism become a digital subscriber to The Courier For as little as 5.99 a month you can access all of our content, including Premium articles.

Totus Medicines Partners with Mila to Advance Drug Discovery Technologies in Mission to Treat the Untreatable News provided by Mar 24, 2022, 07:37 ET Share this article Share this article Organizations to combine expertise to further develop AI/ML-powered drug design platform, delivering precise, effective, and life-changing medicines at scale CAMBRIDGE, Mass. , March 24, 2022 /PRNewswire/ -- Totus Medicines, a drug discovery company using revolutionary chemical biology technologies to create life-changing covalent therapeutics for untreatable diseases, today announced the start of a collaboration with Mila, the Quebec artificial intelligence (AI) institute, which rallies the largest concentration of academic deep-learning researchers. The AI-focused partnership will enable both organizations to leverage each other's distinct expertise and knowledge for drug discovery. This effort comes at a particularly important time for Totus, as the company is on track to advance a drug candidate into first-in-human clinical trials later this year. "We are very excited about this partnership and the technological and drug development progress that can eventually result from it," said Totus Chief Data Officer Dr. John Davies , Ph.D. "Artificial intelligence plays a key role in the development of Totus' drug discovery platform. A partnership with Mila gives us access to some of the brightest minds in AI, which will surely help us take our platform to the next level to treat the untreatable with even more precision and efficiency." "Totus' drug design platform has great potential, and we are eager to collaborate and offer our research and know-how," said Stphane Ltourneau, Executive Vice President at Mila. "Totus' chemical biology expertise, coupled with our AI expertise, has the potential to transform the process of drug discovery as we know it." The partnership will also help Totus attract and retain talented individuals during a time of rapid growth, as the company plans to expand internally through the hiring of over 50 new employees this year. Having access to Mila's extraordinary talent pool will lead to promising opportunities and potential future hires. About Totus Medicines Founded in 2019, Totus Medicines uses revolutionary chemical biology to create life-changing therapies to treat previously untreatable diseases across the entire human genome. Totus is based in Cambridge, Massachusetts

Onaqui Wild Horses in Utah | Photo Credit: Jen Rogers, Wild Horse Photo Safari Animal Wellness Action Executive Director Marty Irby Wayne Pacelle Ending Transport of Horses Across State and National Lines Will Have the Effect of Banning the Trade, Notes Animal Wellness Action We applaud the Members of Congress who are leading this measure and will continue to bring new and creative solutions to ending the most egregious abuses in the equine world Marty Irby, executive director at Animal Wellness ActionWASHINGTON, DC, USA, June 25, 2021 /EINPresswire.com / -- This week, U.S. Reps. Troy Carter, D-La., Brian Fitzpatrick, R-Pa., John Katko, R-N.Y., Dina Titus, D-Nev., and Steve Cohen, D-Tenn. introduced an Animal Wellness Action-conceived amendment to H.R. 3684, the Investing in a New Vision for the Environment and Surface Transportation in America (INVEST) Act, to ban transport of equines across state lines or to Canada or Mexico for slaughter for human consumption. This amendment, if enacted into law, would prevent a cruel and predatory trade that claims the lives of tens of thousands of horses and burros a year at foreign abattoirs. The original amendment was first filed by Carter, Fitzpatrick, and Katko in the House Transportation and Infrastructure Committee and withdrawn with the consent of Chairman Peter DeFazio , D-Oregon, so it could be perfected. Rep. Titus wanted to cover extend protections to burros and additional work has been done to make it even more workable, and Rep. Cohen wanted to join in with the idea of linking the anti-slaughter provisions with a provision in the bill to forbid use of double-deck trailers to carry horses and burros. The revised amendment filed must still clear the House Rules Committee in order to secure a vote next week, and that prosect is more likely with a surge in support for the measure. The amendment has picked up additional cosponsors, including Reps. Jan Schakowsky, D-Ill., and Vern Buchanan (the lead authors of the stand-alone anti-horse slaughter bill); Reps. Paul Tonko, D-N.Y., and Andy Barr, R-Ky., (co-chairs of the Congressional Horse Caucus); and Reps. Buddy Carter, R-Ga., Donald Payne, D-N.J. and Guy Reschenthaler, R-Pa. bringing the total cosponsors to 6 Democrats and 6 Republicans. The measure has been endorsed by more than 225 animal and equine groups, orgs., rescues, and businesses in the U.S. ''Our iconic American equines drove commerce and the development of infrastructure in the first 150 years of the republic, and it's fitting that the INVEST Act pay a debt to them by halting their ruthless exploitation from kill-buyers who cart them off to Canada and Mexico for butchering.'' said Marty Irby , executive director at Animal Wellness Action, who was recently honored by Her Majesty, Queen Elizabeth, II for his work to protect horses. ''We applaud the Members of Congress who are leading this measure and will continue to bring new and creative solutions to ending the most egregious abuses in the equine world.'' ''Rep. Troy Carter was a leader on animal welfare issues in the Louisiana State Senate, and he is picking right back up by leading the amendment to stop the commerce in horses for slaughter,'' said Wayne Pacelle, president of the Center for a Humane Economy. ''Business and enterprise in our nation must be robust, but it must also be humane. Shedding horse slaughter is good for the economy and character of our nation.'' Background: Horses are revered and cherished in the United States, and 80 percent of Americans oppose the slaughter of horses for human consumption. As public awareness has grown of the inherent cruelty involved in the horse slaughter industry, calls for a federal response have grown louder as the federal Bureau of Land Management (BLM) has been implicated in a suspect adoption plan that is allowing ''adopters'' to rake in profits by selling horses and burros to slaughter. Transport of horses for slaughter is unsafe and has caused multiple serious accidents on American highways. The list is long of serious accidents on American highways involving trucks loaded with horses bound for slaughter. Most of these involve horrific injuries to and deaths of horses on the trucks. As recently as October 2020, 14 horses were killed and 11 badly injured when a truck driving the animals to slaughter flipped on a highway in Franklin County, Missouri. Similar accidents have happened over the years, and in most, motorists had to avoid the accident and, in some cases, encountered terrified and injured horses running loose in the lanes of traffic. Similarly, in 2017, a truck belonging to the infamous kill buyers who own one of the nation's largest horse slaughter holding facilities in Bastrop, Louisiana, was involved in a terrible crash that led to the deaths of 19 horses. While horse slaughter does not currently occur on U.S. soil due to a de facto ban achieved through the appropriations process, more than 70,000 domestic and wild horses are shipped to Mexico and Canada each year to be slaughtered for human consumption in those countries, Europe, Asia, and other parts of the world. Stand-alone legislation that would permanently ban both the transportation of slaughter-bound horses and slaughter itself the SAFE Act was recently introduced, but despite the passage of a similar bill fifteen years ago, and the majority of House Members cosponsoring the measure in the 116th Congress, enactment of the legislation continues to be an uphill battle due to industrial agriculture interests and pro-slaughter Members of Congress. Animal Wellness Action (Action) is a Washington, D.C.-based 501(c)(4) organization with a mission of helping animals by promoting legal standards forbidding cruelty. We champion causes that alleviate the suffering of companion animals, farm animals, and wildlife. We advocate for policies to stop dogfighting and cockfighting and other forms of malicious cruelty and to confront factory farming and other systemic forms of animal exploitation. To prevent cruelty, we promote enacting good public policies, and we work to enforce those policies. To enact good laws, we must elect good lawmakers, and that's why we remind voters which candidates care about our issues and which ones don''t. We believe helping animals helps us all. The Animal Wellness Foundation (Foundation) is a Los Angeles-based private charitable organization with a mission of helping animals by making veterinary care available to everyone with a pet, regardless of economic ability. We organize rescue efforts and medical services for dogs and cats in need and help homeless pets find a loving caregiver. We are advocates for getting veterinarians to the front lines of the animal welfare movement; promoting responsible pet ownership; and vaccinating animals against infectious diseases such as distemper. We also support policies that prevent animal cruelty and that alleviate suffering. We believe helping animals helps us all. The Center for a Humane Economy (''the Center'') is a non-pr

Geek of the Week: Adeel Malik, CEO at Clearstep Geek of the Week: Adeel Malik, CEO at Clearstep CW Staff January 29, 2020 Clearstep (formerly known as Lytic) seeks to change the way we deal with diagnosing ourselves. Theres a common trope that if you start typing symptoms into Google, itll eventually tell you that youre going to die, even though all you have is a cold. Clearstep uses an AI-powered chatbot to offer helpful suggestions to patients regarding standard over-the-counter solutions for their medical woes. The companys future seems incredibly bright as the Chicago-based startup has gotten a lot of attention from investors. The company was initially named Lytic as a nod to its analytics system that learned from patients symptoms and offered them an accurate diagnosis. As the company shifted focus away from merely offering a determination to giving the user suggestions for medication, they changed their name. In September of 2019, the company renamed itself Clearstep, since its aim was not just to offer the patient diagnosis, but to provide the next clear steps towards getting better. The company aims to provide a better overall customer experience in healthcare by delivering utterly personalized service to every user. Critical to its success is the companysCEO, Adeel Malik. Formerly a Health and Life Sciences consultant with Accenturein the Washington DC metropolitan area, Adeel worked as a researcher withinJohns Hopkins University School of Medicine after graduating with a dualBachelor of Science, Finance, and Neurobiology in 2015. Understanding the crisisof customer experience in the healthcare sector. Adeel decided that the timewas right to leverage technology and artificial intelligence to create a systemthat users would be glad to utilize. Americans, in general, have had anaversion to visiting doctors over the past decades, and having an AI-basedchatbot to help diagnose and point them in the right direction seemed like itwould take off. Clearstep is only now beginning to surfaceon investors radars. It offers consumers not just the benefit of a doctorsvisit without the need to leave their homes, but also a transparent idea of thecosting of their medication. Adeels background in science research and financemakes him an ideal candidate with a unique experience that covers both scienceand business. His reputation speaks for itself. Thanks to his presence, thecompany has already managed to raise over $400,000 worth of seed funding. Thismoney will go a long way towards making this towards making the dream of thiscompany into a reality. Only time will tell if Adeels attempt to create a morepersonable healthcare system will gain traction. However, with the way most ofus think about visiting a doctor, many people would likely utilize the serviceif only to avoid going into a doctors office. Related Articles

Julian Horsey Contraband is a new game from Avalanche Studios and Xbox Game Studios, offering gamers a cooperative smugglers paradise set in the fictional world of 1970s Bayan, check out the trailer below to learn more about what you can expect from the games location and storyline. Contraband is brought to life by the latest iteration of Avalanche Studios Groups Apex Engine and built to take full advantage of Xbox Series X and the consoles unique capabilities. Contraband is our most ambitious game yet and working closely together with Xbox Games Studios has been a great experience, said Omar Shakir, Game Director at Avalanche Studios. We cant wait to share more about the game and the world of Bayan. Were incredibly excited to work together with a partner such as Xbox Game Studios and look forward to laying the foundation for a long-standing partnership, said Pim Holfve, CEO at Avalanche Studios Group. With Contraband, were taking everything weve learned from 18 years of being in the forefront of open world games as well as bringing the knowledge from running successful live game services focusing on our player communities. Watch this video on YouTube We are excited to partner with the talented team at Avalanche Studios for Contraband, said Peter Wyse, GM of Publishing at Xbox Game Studios. Experiencing the emergent, open-world craziness of an Avalanche Studios game together with your friends is something we cant wait to bring to players. Source :

Associate Editor, St. Louis Business Journal Jan 11, 2022 Pathways Health and Community Support LLC, a Maryland Heights-based provider of behavioral and mental health services, has acquired an Arizona-based company that provides a range of child and adult welfare services. Pathways said last week it acquiredHuman Resource Training Inc. (HRT), an Phoenix-based company that provides foster care services, social services and training to families and youth in central and northern Arizona. HRTs programming includes services for families with children who reside with their biological parents, as well as families with children in out-of-home placements and the developmentally disabled population. Terms of the deal weren't disclosed. Pathways officials said the acquisition complements its social service and behavioral health programs, extending its Arizona footprint from eight to twelve counties and boosting services in Maricopa and Pima counties, two of Arizona's largest counties. Acquiring HRT significantly expands our capacity to provide essential services for more clients in Arizona; this acquisition also supports Pathways strategic plan for continued growth and expansion of our programs which deliver critical behavioral and mental health services," Pathways CEO Jill Winters said in a statement. HRT is Pathways' second acquisition in recent months. Pathways acquiredRenew Consulting, an Albany, Oregon-based provider of customized, support for individuals with developmental disabilities and mental health needs, in October. Founded in 1997 at Providence Services Corp., Pathways was acquiredby Los Angeles-based private investment firm Atar Capital in October 2018 from Molina Healthcare Inc. Pathways, which employs more than 5,000 staff members, moved its headquarters to the St. Louis areafrom Fredericksburg, Virginia, in early 2020. Pathways serves clients in 18 states and the District of Columbia with behavioral health services including counseling, telehealth, autism services, case management, therapeutic foster care, parent education, supportive employment, substance use services and employer-based programs. By

March 20, 2022 Creator earnings wont be affected by the fundraising campaign, although Epic has encouraged creators to partner up with an organization of their choosing if they wish to support the efforts. Epic will separately fund all Creator affiliate payments from code usage between March 20, 2022 and April 3, 2022, so that all of Epics Fortnite proceeds earned during that time period can be distributed to humanitarian relief organizations, the developer wrote in a FAQ. Epic Games isnt the only company thats encouraging players to help give back to those in need.

Signing out of account, Standby... Rootine Brings Bespoke Design to Your Body With a Customized Vitamin Supplement It's testing program helps Rootine identify and, ideally, to fix your key nutritional trouble spots. By StackCommerce February11, 2022 Disclosure: Our goal is to feature products and services that we think you'll find interesting and useful. If you purchase them, Entrepreneur may get a small share of the revenue from the sale from our commerce partners. Multivitamins have taken their fair share of beatings in the court of public opinion. A study by Johns Hopkins found most vitamin and mineral supplements dont have much of an impact on a persons risk for heart disease or cancer. Yet another report found they also dont reduce cognitive decline. Meanwhile, still more research worries that many vitamin E and beta-carotene supplements can provide dosages that are too high for most takers. Rootine The problem with most multivitamins is that they are created to be taken by virtually anyone. Average supplement loads of the most common vitamins and minerals dont address each persons very specific physiology. For example, if you enjoy a diet rich in Vitamin E, but youre dangerously short on iron, a standard off-the-shelf multivitamin may not deliver any of the supplemental value you exactly need. Rootine aims to take the homogenization and guesswork out of the supplement game, offering a multi-nutrient that works for each user because its "meticulously designed" to augment each users body, the company says. Based on a user's specific lifestyle, blood tests, and own DNA, Rootine creates a vitamin mixture with the optimal levels of the exact nutrients that person needs. It all starts with a a short lifestyle assessment drilling into health goals, diet, activity, and more. That helps set your baseline range for each nutrient. But slight variations in your genes can alter how you absorb, metabolize, and distribute nutrients. And no test offers a more cohesive picture of someones nutrient levels than their own blood. Members can also receive DNA and blood tests to further individualize their body chemistry, pinpointing the exact bespoke formula of vitamins and minerals that will best supplement them, the company says. With the help of artificial intelligence, Rootine builds what it says is your perfect multi-nutrient formula from more than 700 trillion possible nutrient combinations in an ultra-condensed, efficient micro-bead formula you take every day. Micro-beads allow for hyper-personalization of formulas, as each nutrient can be dosed to the milligram or microgram. Fine-tuning every nutrient in a customers formula ensures that an optimal nutrient dose is achieved and blood level is maintained over time. Once users start down the Rootine path, members also have access to their own app-based dashboard where they can chart their health progress and better optimize their journey. If youve recently had blood work done through your doctor or obtained DNA results through a genealogy service like Ancestry.com or 23andMe, those results can be input directly to Rootine and save you the cost of the additional testing. Rootine also maintains a highly strict privacy policy, ensuring your biological and personal data is secure and will never be sold or released to any other organization. Many Rootine users like Dr. Gary Cook are also extremely pleased with their results. Great energy throughout my long shifts in the ER, Cook said. I only support products I would use myself. Rootine is giving me, my family, my patients a better life. Right now, you can

. The price targets range from a low of $11.00 to a high of $24.00. Porch Group, Inc. ( PRCH ) PRCH provides software and services under the ISN, HireAHelper, Kandela brands to home services companies, such as home inspectors, homebuyers and homeowners, insurance carriers, moving companies, security companies, and TV/internet providers, as well as offers moving concierge services. In January 2022, Homeowners of America (HOA), a property and casualty insurance provider and a subsidiary of PRCH, announced its service launch in Montana, marking HOAs 14th state of operation. This is in line with HOAs national expansion plan and should increase PRCHs presence in the insurance industry. In December 2021, PRCH introduced its new Pay-At-Close module for home inspection companies to simultaneously make the payment processing experience smoother for homebuyers, agents, and inspectors. The program is available to some inspection companies, and a broad roll-out is expected to begin this year. This solution should be widely in demand and should garner significant returns. PRCHs revenue increased 191.9% year-over-year to $62.77 million for the fiscal third quarter ended September 30 . Also, for the nine months ended September 30, the cash and cash equivalents stood at $415.83 million, indicating an improvement of 5,010.4% year-over-year. The consensus revenue estimate of $54.57 million for the fiscal fourth quarter ended December 2021 indicates an increase of 179.7% year-over-year. Its EPS is expected to improve 22.2% from its prior-year quarter. All of the seven Wall Street analysts that rated the stock have rated it Buy. The 12-month median price target of $28.29 indicates . The price targets range from a low of $21.00 to a high of $34.00. indie Semiconductor, Inc. ( INDI ) INDI operates as an automotive semiconductors and software solutions-based company. The company offers advanced driver assistance systems solutions, including light detection and ranging, connected car, user experience, and electrification applications. Last month, INDI unveiled that it has created a Kabushiki Kaisha, or KK, and added some key resources in Tokyo. The company aims to strengthen its foothold in Japan, one of the largest global automotive markets. In December 2021, INDI launched the Surya LiDAR system-on-a-chip (SOC), enabling advanced driver assistance systems (ADAS) and autonomous driving functionality. This breakthrough development demonstrates its prowess in advancing architecture and should allow it to cash in on the fast-advancing lidar technology. INDIs total revenue increased 60.3% year-over-year to $12.16 million in the fiscal third quarter ended September 30. Its non-GAAP gross profit stood at $5.23 million, up 33.3% from the prior-year quarter. The consensus revenue estimate of $21.53 million for the fiscal first quarter ending March 2022 indicates an increase of 165.4% year-over-year. Also, its revenue is expected to grow 172.3% year-over-year in the next quarter. Each of the three Wall Street analysts that have rated INDI rated it Buy. The 12-month median price target of $18.33 indicates . The price targets range from a low of $16.00 to a high of $22.00. Allot Ltd. ( ALLT ) Based in Hod-Hasharon, Israel, ALLT provides network intelligence and security solutions to protect and personalize the digital experience worldwide. The company offers Allot Service Gateway (Allot SG) platforms, including Allot SG-Tera, Allot SG9x000, Allot SG-VE, and CE for in-line deployment in traditional and virtualized network access infrastructure. Last month, ALLT announced that Entel, Perus innovative communication service provider, has launched the Allot NetworkSecure cybersecurity solution to protect the companys mobile users against a broad range of cyber threats. Entel and ALLT will share recurring revenues generated by monthly service fees. Earlier, Play, the leading mobile operator in Poland, and Field Solutions Group (FSG), Australias leading rural, regional, and remote challenger telecommunications carrier, selected ALLT cybersecurity solutions to protect customers against cyber threats. Several other companies also chose ALLTs security solutions over the past few months, reflecting ALLTs dominance in the cybersecurity space. ALLTs revenues increased 9.8% year-over-year to $38.16 million in the fiscal third quarter ended September 30, while its non-GAAP gross profit grew 11.9% from the year-ago value to $26.84 million. Analysts expect the companys revenue to increase 4.1% year-over-year to $40.70 million for the fiscal fourth quarter ended December 2021. Of the four Wall Street analysts that have rated ALLT, three rated it Buy, while one rated it Hold. The 12-month median price target of $18.75 indicates . The price targets range from a low of $14.00 to a high of $23.00. Want More Great Investing Ideas?

Western Located in Bellevue, Wash., Aegis Living Bellevue Overlake features 122 senior living apartments. BELLEVUE, WASH. Aegis Living has opened Aegis Living Bellevue Overlake, located in the city of Bellevue where the company is headquartered. The community features 122 senior living apartments in the 106,000-square-foot-building. Its opening follows Aegis Livings joint acquisition of 10 communities across California, Washington, and Nevada. Aegis has eight additional communities in development, including communities in Kirkland and the Eastlake neighborhood of Seattle. Aegis Living Bellevue Overlake is the first community Aegis Living has designed to be fully centered in the scientific benefits of biophilia and the innate connection to nature, a concept that has been shown to elicit a therapeutic response both physical and emotionally, according to Aegis. We are delighted to open a community that is rooted in nature, bringing the outdoors in and creating an oasis in the city, particularly coming out of a year when the COVID-19 pandemic demonstrated just how important home is, says Aegis founder, CEO and chairman Dwayne Clark.

growOptimum , a trusted cleanroom facility builder/designer and manufacturer. "We are excited to take part in this week's event with growOPTIMUM and we look forward to meeting like-minded people in the cannabis sector," said Wade Helms of the Edd Helms Group. "The Edd Helms Group has been a leader in building projects, electrical work and HVAC in Florida since 1975. We couldn't be happier to be partnering with them and exhibiting with them this week, said Vern Solomon, President of growOptimum. If you would like to know more, be sure to stop by and visit booth 816. -30- About Cannabis Industrial Marketplace: The foundation of the Cannabis Industrial Marketplace, "The Business of Cannabis" is a free to use online sourcing tool of nearly 4,000 Cannabis friendly suppliers. The online resource is utilized by Cannabis cultivators and dispensaries to find new business partners. Coupled with this online presence, CIMP also produces a series of expos and educational cannabis business seminars in emerging markets across the United States. About Edd Helms Group: Edd Helms Group and its family of companies, including Edd Helms Air Conditioning & Electric as well as Gulfstream Controls, have been a part of the South Florida community beginning in 1952 with McDonald Air Conditioning. About growOptimum: We like to say "We Know the Grow." This means we know the physics required to control temperature and humidity, GMP requirements, and how they impact facility design. We know how to assess your facility to spot potential issues before they become major problems, to design and build a facility that will meet the requirements of your grow. Contact Information

Building on the momentum created in its international markets in 2021, Keller Williams is growing its presence in the Caribbean with the launch of a new master franchise in Sint Maarten, the Dutch-owned side of Saint Martin island. William Soteroff | Photo credit: Keller Williams Were excited to announce KW Sint Maarten, our sixth master franchise in the Caribbean, which we expect will thrive under the leadership of Maayke de Haan, a renowned real estate veteran and business leader on the island, Keller Williams Worldwide(KWW) President William E. Soteroff said in a prepared statement on Wednesday. We currently have more than 1,000 agents across the Caribbean regions of Aruba, Dominican Republic, Jamaica, Puerto Rico, and Turks & Caicos. Veteran broker Maayke de Haan will lead KWWs operations on the island. De Haan moved from Belgium to Sint Maarten in 1991 and began her real estate career in 1998. Ten years later, de Haan founded Antilles Realty, which has become one of the top boutique brokerages for buyers, sellers and investors searching for property and land throughout the Caribbean. Maayke de Haan Antilles Realty will be co-rebranded as KW Sint Maarten, and de Haans four-agent team will continue to operate out of their Cayhill office. We joined Keller Williams for its systems and models that have proven to work all over the world. We share a love for real estate and a culture of caring, said de Haan in a written statement. Truly a win-win situation, we look forward to leveling up with KW and growing to be the No. 1 real estate company of choice in Sint Maarten. Added Soteroff, As always, we seek to find the best leaders to guide our brand experience with every expansion into a new country and region, and de Haan symbolizes that high standard we have set. Despite travel and immigration restrictions, Keller Williams international operations grew steadily throughout 2021 with the franchisor launching master franchises in Slovenia, Thailand, Uruguay, Aruba, the Dominican Republic, Peru, Suriname, Paraguay, Serbia, Honduras, Turks and Caicos and Brazil. As of their latest earnings report in November , Keller Williams Worldwide outpaced Keller Williams North American operations. While agents in Canada and the U.S. saw their annual transaction volume (-0.8 percent), new listings (-1.8 percent) and new contracts (-3.5 percent) slip, agents in KWW regions experienced their best year yet with transactions and sales volume increasing 36.3 percent and 74.5 percent year over year, respectively. Soteroff said KWW is primed to outdo their 2021 performance, as its international agent count increased 23 percent year over year in December alone. That momentum will be used to launch new franchises in Africa, Central and South America, Central and Eastern Europe and Asia in the coming year. No one predicted the challenges of 2021, yet our international operations are thriving and were growing at a faster clip than ever, he said. And, thats due to a steadfast commitment to our values and principles and to providing the industrys best agent training. The massive real estate franchisor now has 287 market centers across 50 regions representing nearly 15,000 agents.

December 16, 2021 The Hobart class destroyer, HMAS Sydney. (ADF) Lockheed Martin Australia has been awarded a $33 million design contract to support the upgrade of the Royal Australian Navys Hobart class destroyers Aegis combat systems. This contract falls under the Project SEA 4000 Phase 4 Combat System Design Agent (CSD-A), part of a series of upgrades planned for the three-ship Hobart class which achieved a full operational capability milestonein August. Lockheed Martin Australia will perform most of the naval combat systems engineering services work in Adelaide, with industry partners including Relegen, a Sydney-based maritime data specialist that will support configuration updates associated with CSD-A activities, and Saab Australia for the Australian interface integration. The work will precede the integration of the Aegis Combat System Baseline 9 (BL9)software which will provide an enduring baseline for the RANs ongoing sustainment of the Aegis combat system. As the manufacturer of Aegis, the worlds most advanced combat system, Lockheed Martin Australia is proud to deliver and sustain capabilities that play a critical role in the defence of Australias interests, as well as those of our allies in the Indo-Pacific, Lockheed Martin Australia Chief Executive, Warren McDonald said in a company release. Lockheed Martin Australia looks forward to collaborating with the Royal Australian Navy, industry partners and the US Navy to ensure the successful upgrade and ongoing sustainment of Australias Aegis Combat System, he added. This initial Phase 4 contract covers the design of how the Baseline 9 combat system will integrate with the vessel and its sensors, as well as the Saab Australian interface which will also be installed. It will include a requirements definition phase, a systems design review, and systems engineering prior to production which will be covered under a wider-ranging upgrade project for the vessels. The upgrade will make it easier to adapt ballistic missile defence technology into the vessels, will make the combat systems common with those of the Hunter class frigates which will be delivered with Baseline 9, and will also place the RAN closer to the US Navy, giving the two services an ability to jointly prosecute targets in a taskforce scenario Because Lockheed Martin is the OEM of Aegis and the system uses a common source library, the company is confident that the design and systems engineering phase will be relatively trouble-free. The upgrade will also include a move to commercial-standard hardware housed in ruggedised containers instead of the previous mil-standard hardware. Lockheed Martin Australias Acting Director of RMS Operations and Integrated Warfare Systems & Sensors Line of Business Lead, Rob Milligan added, The Lockheed Martin Australia team will leverage the best of Australias industrial capability base to deliver complex Aegis Combat System Baseline 9 upgrades, while supporting a harmonised combat systems enterprise across both Hobart class destroyers and future Hunter class frigates. Baseline 9 is the current Aegis software configuration used on the US Navys Arleigh Burke Flight II destroyers and remaining Ticonderoga class cruisers. The adoption of Baseline 9 follows US approval of the Commonwealths planned acquisitionof Raytheon SM-2 Block IIIC and RIM-174 Standard Extended Range Active Missile (ERAM) (SM-6) Block I surface-to-air missiles for the Hobart class, with the SM-6 in particular having the capability to intercept ballistic missiles. Other Aegis operators in the region Japan and South Korea are also following a similar upgrade path, with Korea charting a parallel course with Australia, and Japan slightly ahead. The Hobart class upgrade production phase is scheduled to commence in mid-2024. 0

Medical Diagnostic Laboratories, L.L.C., (MDL) , a Genesis Biotechnology Group (GBG) company and CLIA-certified, CAP-accredited laboratory specializing in high-complexity, state-of-the-art, automated DNA-based molecular analyses, has expanded its testing to include a comprehensive program for the detection of vector-borne diseases. Unfortunately, new tick- and mosquito-borne diseases continue to emerge, increasing in prevalence year after year.The Centers for Disease Control and Prevention (CDC) has reported that the number of disease cases from mosquitoes, ticks, and fleas has tripled from 2004 to 2016. Ticks and mosquitos that carry bacterial, parasitic, and viral pathogens continue to increase in number, species, and geographic range. Currently, tick-borne diseases are widely distributed throughout the United States , with major concentrations in the Northeast, Upper Midwest, and across the middle of the Midwest and Atlantic states. To combat this growing medical issue, MDL has renewed their efforts to provide the most comprehensive vector-borne disease test menu. Their multi-phase implementation will offer a comprehensive platform blending direct (molecular testing) and indirect (serological) testing methods. This important information helps providers determine their patients exposure risk, the pathogen(s) associated with often-overlapping symptomatology, the most effective antimicrobial treatment for active infections, and appropriate prophylactic treatment for exposure. Phase Two, expected to launch in Q2 2019, will feature tick identification. MDL will also offer immune status testing using flow cytometry to evaluate CD3-/CD8-/CD57+ natural killer cells and other immune markers to help assess treatment response for acute and Post-treatment Lyme disease Syndrome patients. Testing will detect a variety of pathogens associated with tick-borne disease including Borrelia species (US and European strains of Lyme disease and Relapsing fever), Rickettsia species (Spotted Fever and Typhus Fever), Ehrlichia

CABLES: FIBER optical cable without sheath. (photo credit: REUTERS/ALESSANDRO BIANCHI) Advertisement While Israel leads the world in technological and medical advances, what the country has been lacking lies within its own borders: accessibility to high-speed fiber opticinternet for its citizens from the North to the South. In Israel, the internet is available everywhere, from buses to trains, cafes to restaurants, health clinics to gym clubs, but it is just Wi-Fi. While the world began going through a fiber optic revolution in the early portion of the last decade, Israel has only just begun its journey. cnxps.cmd.push(function () { cnxps({ playerId: '36af7c51-0caf-4741-9824-2c941fc6c17b' }).render('4c4d856e0e6f4e3d808bbc1715e132f6'); }); if(window.location.pathname.indexOf("/jpost-tech/")!=-1){ document.getElementsByClassName("divConnatix")[0].style.display ="none"; var script = document.createElement('script'); script.src = 'https://static.vidazoo.com/basev/vwpt.js'; script.setAttribute('data-widget-id','616dd69d1b04080004ac2cc0'); document.getElementsByClassName('divVidazoo')[0].appendChild(script); }else if(window.location.pathname.indexOf("/israel-news/") != -1 || window.location.pathname.indexOf("/omg/") != -1 || window.location.pathname.indexOf("/food-recipes/") != -1 || window.location.pathname.indexOf("/science/") != -1){ document.getElementsByClassName("divConnatix")[0].style.display ="none"; var script = document.createElement('script'); script.src = 'https://static.vidazoo.com/basev/vwpt.js'; script.setAttribute('data-widget-id','60fd6becf6393400049e6535'); document.getElementsByClassName('divVidazoo')[0].appendChild(script); }else if(window.location.pathname.indexOf("/health-and-wellness/") != -1){ document.getElementsByClassName("divConnatix")[0].style.display ="none"; var script = document.createElement('script'); script.src = 'https://player.anyclip.com/anyclip-widget/lre-widget/prod/v1/src/lre.js'; script.setAttribute('pubname','jpostcom'); script.setAttribute('widgetname','0011r00001lcD1i_12246'); document.getElementsByClassName('divAnyClip')[0].appendChild(script);} One might expect that all major cities such as Jerusalem, Tel Aviv and Haifa would have this sort of infrastructure as standard, but at the moment, only 42% of the country has access to these high-speed capabilities, according to Communications Minister Yoaz Hendel. That leaves some sections of Tel Aviv, the tech capital of the world, without access to high-speed fiber optics, and naturally many in the periphery. While Israel is years behind the fiber opticsrevolution, the most unlikely new player in the country is fast-tracking the ability for Israelis to have access to these technologies: Mekorot, Israels national water company. Mekorot has been dipping its toes into the tech sector waters as of late, developing innovations that could be applied to multiple sectors in Israel, and the world. Mekorot, which has been operating in the country since 1937, began investing heavily in breakthrough technologies in March of 2018, when the Knesset approved an initiative allowing companies like Mekorot, who are involved with and subsidized by the Israeli government, to do so. Mekorot, listed on the Tel Aviv Stock Exchange, is a government company that operates under the Infrastructure, Energy and Water Resources Ministry, providing 80% of the drinking water in Israel with operations accounting for 70% of overall water consumption in the country. It is also a world leader in big data, energy management, water quality and cyber protection with innovative developments that have proven themselves in the field. FIBER OPTICS of a cable without sheath. (credit: REUTERS/ALESSANDRO BIANCHI) Mekorots technologies improve the quality of water production and its consumption, and provide a myriad of benefits to the Israeli economy, while reducing the cost of living. They could also greatly improve the energy consumption, big data and cybersecurity sectors across the world, among other examples. Focusing on fiber optics, the water company developed a way to fish fiber optic lines throughout the country using its already existing pipeline infrastructure that stretches from the far reaches of the North back down to the southern borders. One of the recent projects that were dispatched was to connect the Negevs capital the city of Beersheba to Eilat, through a 280-km. pipeline. We got the idea from the army, Mekorot chief technology officer Moti Shiri explained. The fiber optics are used by the army along the road to listen to noise stemming from long distances. Whether it be a car, people or animals, the technology can pick up and pinpoint the sounds from far away. We didnt start this project for communication capabilities, our goal was to change the pipe to a smart pipe, Shiri said. We wanted to know in every centimeter or every inch of pipe what is happening in real time. The fiber optics discovery ended up being just a plus to the equation, a plus that could save the Israeli economy and its citizens billions a year and countless hours of work in the process. This makes it a prominent option to provide high-speed internet to the entirety of the country especially sections that would otherwise not have access at a lower cost than it would have originally been if the fiber optics cables were to be disseminated using non-existing infrastructure infrastructure that would either have had to be commissioned or constructed from scratch. Our goal now is to connect the entirety of Israel to fiber optics, Shiri said. Not all of Israel is connected to fiber optics, and to connect them across the entire country costs a lot of money and takes a lot of time. Shiri said that considering Mekorot has pipes all across the country even in the remote sections that by using the pipes, communications companies can connect to these remote areas quickly, instead of waiting three to four years to do it. If the infrastructure would have had to have been built from scratch, it could cost the Israeli economy billions in construction, deployment, digging, permits and creating the overall infrastructure companies would need to house the fiber optic lines within. Additionally, as a separate plus, Mekorot forwards the option to use indoor facilities for the construction of a data center and Hub. Mekorot itself, is the owner of more than 13,000 km. of existing and protected underground infrastructure throughout Israel, which constitutes as essential valuable real estate for a fiber network deployment real estate which will all eventually be filled with fiber optic capabilities. To disseminate the lines throughout the country, Mekorot fashioned a way to insert fiber optics cables into the pipelines and dispatch them throughout the country 2 km. at a time using an innovative system that uses both water and air pressure to carry and transp

Heather Hollingsworth and Michael Kunzelman/AP Posted: Sep 3, 2021 / 12:33 AM CDT | Updated: Sep 3, 2021 / 12:33 AM CDT Nurses and medical staff make their way through the seventh floor COVID-19 unit at East Alabama Medical Center Thursday, Dec. 10, 2020, in Opelika, Ala. COVID-19 patients occupy most of the beds in ICU in addition to the non-critical patients on the seventh floor. (AP Photo/Julie Bennett) MISSION, Kansas (AP) The COVID-19 pandemic has created a nurse staffing crisis that is forcing many U.S. hospitals to pay top dollar to get the help they need to handle the crush of patients this summer. The problem, health leaders say, is twofold: Nurses are quitting or retiring, exhausted or demoralized by the crisis. And many are leaving for lucrative temporary jobs with traveling-nurse agencies that can pay $5,000 or more a week. Its gotten to the point where doctors are saying, Maybe I should quit being a doctor and go be a nurse, said Dr. Phillip Coule, chief medical officer at Georgias Augusta University Medical Center, which has on occasion seen 20 to 30 resignations in a week from nurses taking traveling jobs. And then we have to pay premium rates to get staff from another state to come to our state, Coule said. Death toll tops 40 after Ida remnants slam stunned Northeast The average pay for a traveling nurse has soared from roughly $1,000 to $2,000 per week before the pandemic to $3,000 to $5,000 now, said Sophia Morris, a vice president at San Diego-based health care staffing firm Aya Healthcare. She said Aya has 48,000 openings for traveling nurses to fill. At competitor SimpliFi, President James Quick said the hospitals his company works with are seeing unprecedented levels of vacancies. Small to medium-sized hospitals generally have dozens of full-time openings, and the large health systems have hundreds of full-time openings, he said. The explosion in pay has made it hard on hospitals without deep enough pockets. Kansas Gov. Laura Kelly lamented recently that the states hospitals risk being outbid for nurses by other states that pay a fortune. She said Wednesday that several hospitals, including one in Topeka, had open beds but no nurses to staff them. In Kansas City, Missouri, Truman Medical Centers has lost about 10 nurses to travel jobs in recent days and is looking for travelers to replace them, said CEO Charlie Shields. He said it is hard to compete with the travel agencies, which are charging hospitals $165 to $170 an hour per nurse. He said the agencies take a big cut of that, but he estimated that nurses are still clearing $70 to $90 an hour, which is two to three times what the hospital pays its staff nurses. I think clearly people are taking advantage of the demand that is out there, Shields said. I hate to use `gouged as a description, but we are clearly paying a premium and allowing people to have fairly high profit margins. In Texas, more than 6,000 travel nurses have flooded the state to help with the surge through a state-supported program. But on the same day that 19 of them went to work at a hospital in the northern part of the state, 20 other nurses at the same place gave notice that they would be leaving for a traveling contract, said Carrie Kroll, a vice president at the Texas Hospital Association. The nurses who havent left, who have stayed with their facilities, they are seeing these other people come in now who are making more money. It provides a tense working environment, Kroll said. The pandemic was in its early stages when Kim Davis, 36, decided to quit her job at an Arkansas hospital and become a travel nurse. She said she has roughly doubled her income in the 14 months that she has been treating patients in intensive care units in Phoenix; San Bernardino, California; and Tampa, Florida. Since Ive been traveling, Ive paid off all my debt. I paid off about $50,000 in student loans, she said. Davis said many of her colleagues are following the same path. Theyre leaving to go travel because why would you do the same job for half the pay? she said. If theyre going to risk their lives, they should be compensated. Has the delta variant peaked? COVID-19 data gives glimmer of hope Health leaders say nurses are bone-tired and frustrated from being asked to work overtime, from getting screamed at and second-guessed by members of the community, and from dealing with people who chose not to get vaccinated or wear a mask. Imagine going to work every day and working the hardest that you have worked and stepping out of work and what you see every day is denied in the public, said Julie Hoff, chief nurse executive at OU Health in Oklahoma. The death that you see every day is not honored or recognized. Meanwhile, hospitals are getting squeezed by the revolving door of departures and new hires from traveling agencies. Coule cited a recent example in which his hospital in Georgia hired a respiratory therapist through an agency to replace a staff member who had decided to accept a traveling gig. The replacement came from the same hospital where his respiratory therapist had just gone to work. Essentially we swapped personnel but at double the cost, he said. Patricia Pittman, director of the Fitzhugh Mullan Institute for Health Workforce Equity at George Washington University, said many nurses still harbor resentment toward their employers from the early stages of the pandemic, in part from being forced to work without adequate protective gear. The nurses say, Hey, if I am not going to be treated with respect, I might as well go be a travel nurse,' she said. That way I can go work in a hellhole for 13 weeks, but then I can take off a couple months or three months and go do whatever.' Latest News

Response Link Cost: Starting at $19.95/month ResponseLINK has come a long way during their almost 20 years in the medical alert systems industry. Originally created out of a partnership between Advantor Corp. and Bell South, this company has moved away from its previous distributor-based sales model with an updated, easy-to-use website that allows customers to order directly - no salesperson required. You'll find two basic, no-frills options when buying a medical alert system through ResponseLINK. Neither plan requires a long-term contract or equipment fees, and both come with free 1-5 business day shipping: In-Home Alert: starting at $19.95/month, this system uses a landline to connect users to their 24/7 monitoring center. The waterproof, wearable pendant-style panic button has a 600-foot range from the base station. If you'd like a system that automatically detects falls, you can choose the system that includes that feature for $30.95/month. The ResponseLINK site doesn't specify whether that system usesa landline, but the equipment photos look exactly like the In-Home system - so it's probably safe to assume you'll need a landline. Mobile Alert: starting at $30.95/month, this system uses a device that looks something like an old-style pager and uses GPS location through the T-Mobile cellular network to provide help wherever the person goes. We weren't thrilled to see that the ResponseLINK site proudly proclaims an A+ rating with the Better Business Bureau, because the BBB site showed a lower grade of just "A". Most of the complaints there centered around their sister site, Alert1, which offers several equipment/service plans not available through ResponseLINK. One frequent area of complaint is billing. You can save money by paying for your medical alert service annually or semi-annually, but buyer beware: we found many customers complaining that they were not able to get a refund for unused months if they had to cancel the service (e.g. if the user passed away or entered hospice care). You can only get ResponseLINK's "30 day risk-free money-back guarantee" onservice planspaid in advance, not monthly billing, but for many customers that just means a big fight with customer service to actually get their prepaid money back. Seniors and their caregivers need the best technology combined with excellent customer service and hassle-free billing. ResponseLINK's medical alert systems fall very short in all three of those criteria. We strongly suggest you choose a more customer-friendly service provider.

CareSouth donates $1.4M to Southern University CareSouth donates $1.4M to Southern University By | August 11, 2020 at 2:00 PM CDT - Updated August 11 at 5:22 PM BATON ROUGE, La. (WAFB) - Healthcare provider CareSouth Medical and Dental is donating $1.4 million to Southern University in Baton Rouge. CareSouth CEO Matthew Valliere presented Southern University System President-Chancellor Ray L. Belton with the check on Southerns campus Tuesday, Aug. 11. Officials say the money will be used to help fund the CareSouth/SU Employee Wellness Clinic, the SU College of Nursing and Allied Health Scholarship Fund, SU Athletics, the SU Human Jukebox, and the Valdry Center for Philanthropy. The funds will be distributed to the university over five years, according to a company spokesperson. CareSouth Medical and Dental donated $1.4 million to Southern University in Baton Rouge, La. on Tuesday, Aug. 11, 2020 (Source: CareSouth Medical and Dental) Today represents a new chapter in the relationship between CareSouth and Southern University that started with the Athletic Department three years ago and has expanded to help bridge the gap between health, wellness, and education, Valliere said. We share a similar mission in helping vulnerable populations and were excited to give this donation to assist this great institution and pillar in our community in continuing the exceptional work that they do in preparing our future workforce. We are extremely grateful for this gift from our community partner CareSouth, Belton said. This funding will impact not only our students in these programs, but also our faculty and staff who have a major role in student success. We look forward to continuing to bring to fruition projects and scholarships made possible by CareSouth.

Cellectricon and StressMarq Biosciences collaborate to develop next generation reagents and assays to advance neurodegenerative disease research Share Article Cellectricon announce collaboration with StressMarq Biosciences, a leading provider of reagents for neurodegenerative disease research. Access to StressMarqs portfolio of fibrillar protein preparations strongly facilitates Cellectricons work to decipher the etiology of neuropathologies in neuronal circuits on their high capacity discovery platform. Mlndal, Sweden and Victoria, BC, Canada (PRWEB) February 06, 2020 Cellectricon, a collaborative services provider dedicated to advancing drug discovery and research in the areas of chronic pain and neurodegenerative diseases announces a collaboration with StressMarq Biosciences. As a supplier of life science reagents such as primary antibodies, antibody conjugates, proteins, immunoassay kits and small molecules, Stressmarq Biosciences will work with Cellectricon to enable the collaborative development of next-generation reagents and assays for neurodegenerative disease research. Spreading of neurodegenerative disease associated peptides (NDAPs; e.g. amyloid-beta peptides, tau and alpha-synuclein) within the human brain is one of the earliest pathological processes leading to Alzheimers disease and Parkinsons disease. Cellectricon aims to decipher the spreading of neuropathologies in neuronal circuits using a proprietary high capacity microfluidics platform. As more details become known about NDAPs and their cell-to-cell transmission, it may be possible to design novel pharmacological interventions that block disease progression. Methods for targeting the pathological pathways involved in protein misfolding or spreading of the disease to neighbouring neurons are of great interest said Sebastian Illes, Director of CNS research at Cellectricon. A vital factor for enabling in vitro modelling of neuropathological processes is access to well-characterized reagents such as seed competent fibrils and filaments. We are therefore very pleased to announce our collaboration with StressMarq Biosciences as it will enable us to access their high-quality portfolio of reagents for our services he added. StressMarq Biosciences has a unique reagent offering including pre-formed fibrils of tau, alpha-synuclein and other proteins for neurodegenerative disease research. Certain fibrils and filaments can initiate protein aggregation, inducing disease pathology in vitro and in vivo. These proteins can be used to study diseases such as Alzheimers, Parkinsons, ALS, and amyloidosis. We look forward to working with Cellectricon to develop novel assays and reagents for neurodegenerative disease research. This is an excellent opportunity for us to showcase our expertise, products and knowledge base to the scientific community said Ariel Louwrier, President & CEO at StressMarq Biosciences. For more information on Cellectricons Pain and CNS Discovery Services, please visit http://www.cellectricon.com For more information on StressMarq Biosciences cutting-edge products for neurodegenerative disease research, please visit http://www.stressmarq.com/PFFs Share article on social media or email: View article via:

January 10, 2021 The concept for the company was developed after Woodard struggled to find food options for her daughter who had several food allergies. Dedicated to ensuring that healthy options were affordable and accessible and determined to break barriers as a Black woman entrepreneur, Woodard left her corporate job at Coca-Cola and focused on building Partake Foods full-time. She launched a Kickstarter campaign to get her business off the ground and sold cookies from her car. She later received investments from an array of VC firms and angel investors that included Arlan Hamiltons Backstage Capital, The Factory, SoFi Venture, Chuck Muth and Jay-Z. The company announced it closed its Series A round with $4.8 million with new investors that include mogul Rihanna, songstress H.E.R., professional football player Bobby Wagner, the Black Star Fund, the venture capital firm Black Capital and other VC firms. With this group of strategic partners and added financing, Partake continues our mission of making super delicious and safe food that those with and without dietary restrictions can enjoy, Woodard said in a statement, according to the news outlet. The demand for thoughtfully-made cookies, snacks and treats is clear, and we are excited to continue to provide plant-based, safe, and crave worthy foods to consumers. Partake Foods has been added to the shelves of national retailers including Whole Foods Market and Target. Several celebrities are stepping up to invest in Black-owned businesses. Comedian Kevin Hart invested in the company Ellis Island Tea. The companywhich is owned and operated by Nailah Ellisproduces an array of flavorful, all-natural handcrafted teas made with herbs. Ellis venture was inspired by her Jamaican heritage and her great-grandfather Cyril Byrons recipes. Byron was the head chef of s Black Star Line fleet. SEE ALSO:

Save A new Nashville-based personalized nutrition company has raised $3 million in seed financing to build out technology that will provide digital health tracking tools to encourage vitamin and mineral intake among other lifestyle management tools. The funding to launch Rootine was in part led by LaunchTN Impact Fund, with participation from Novogenia, DSM Venturing, Duro VC, Cleo Capital and 20 other angel investors, according to a press release. Rootine offers at-home testing and health data analytics with action insights personalized to each member. The technology, using artificial intelligence, will help the company build out its precision nutrition brand by considering dietary habits, lifestyle, DNA and blood test results and physical activity to determine nutrition recommendations. The company was co-founded in 2018 by Daniel Wallerstorfer, a biotechnician and nutrition expert in Austria, and former NaviHealth strategist Rachel Soper Sanders, who is serving as CEO. She also founded practice management firm Patch Health in 2017 and previously served as an associate for Raymond James Financial in their health care investment banking sector. "The future of health is data-driven and personalized," Soper Sanders said in the release. "We are entering a new era of human performance. An era in which we can achieve optimal health with products designed to enhance fitness, mental acuity, sleep, nutrition, and metabolic health through prescriptive solutions. Finally, there is a health stack for the empowered consumer and Rootine is an essential contributor."

for three years to find out how the zipper manufacturing company is standing the test of time. He published his findings in . The article explains that YKK stands for Yoshida Kogyo Kabushikikaisha. The 88-year old Japanese zipper company produces 10 billion zippers a year. And its manufacturing center sits just off Interstate 16 in Macon. 41NBC interviewed Dr. Cavusgil about the six factors he says contributes to YKKs long-term success.

La Crosse County Circuit Court felonies The pills from both Pfizer and Merck are expected to be effective against omicron because they do not target the spike protein where most of the variants worrisome mutations reside. Pfizer currently has 180,000 treatment courses available worldwide, with roughly 60,000 to 70,000 allocated to the U.S. The company said it expects to have 250,000 available in the U.S. by the end of January. The European Medicines Agency said its decision was made based on a review of the drug's use in people who were mostly infected with the delta variant of COVID-19, but they believed it would also be helpful in curbing the current surge caused by the ultra-contagious omicron variant. Based on laboratory studies, Paxlovid is also expected to be active against omicron and other variants, the regulator said. It said the drug's safety profile was favorable and that side effects were generally mild. Peter Liese, the European Parliament's spokesperson for health, called the decision a real ray of hope for a return to normality after the pandemic. But he cautioned that there were no guarantees from the European Commission or member countries that the drug would delivered quickly. In a statement, Liese said he had recently sent Pfizer's CEO an urgent appeal following EU negotiations to obtain the drug. Follow APs pandemic coverage at

Abhyuday Jindal, MD, Jindal Stainless. The company aims to become a globally certified, end-to-end solution provider in aviation, defence, and space sectors New Delhi, Mar 10 Jindal Stainless (Hisar) Ltd has obtained an AS 9100D Certification, a quality management system for aviation, space, and defence organizations, thereby enabling it to get listed in OASIS - the Online Aerospace Supplier Information System database. Listing on OASIS would allow it to showcase offerings to aerospace manufacturers. AS 9100D certification The AS 9100D certification journey was driven by the top management and implemented by a team of around 120 people across the supply chain, within 15 months, JSHL said in a statement. According to Abhyuday Jindal, MD, JSHL, the company aims to become a globally certified, end-to-end solution provider in aviation, defence, and space sectors. As an internationally recognized benchmark, AS 9100D will help us gain competitive advantage in the global and domestic aerospace marketplace, helping us expand our international footprint, he said. With aerospace emerging as a growing market, and the Centres emphasis on Make in India, AS 9100D Certification is a prime requirement to gain greater access into this segment. JSHL has been catering to the requirements of organizations like ISRO (Indian Space Research Organisation), DRDO (Defence Research and Development Organisation) and BDL (Bharat Dynamics Ltd), VSSC (Vikram Sarabhai Space Centre) among others. In the past, the company supplied 15CDV6 for Satellite Launch Vehicles, Project Gaganyaan, Nuclear Submarine Missile System etc. It is also the first Indian Company to supply critical materials for rocket motor booster application for ISRO. Published on

Australian group EML Paymentshas warned that plans to grow its business in Europe could be stymied as a result of possible orders from the Central Bank of Irelandin relation to its Irish unit, where the regulator is looking into anti-money laundering and counter-terrorism concerns.. In an update to investors, EML said the financial regulator had informed the fintech that its material growth policy is higher than what the Central Bank would want to see. It added that the regulator has proposed that limits be applied to EMLs prepaid programmes, which could have a negative impact on the business, it said. EML was due to present plans to the Central Bank that include a detailed analysis of limits applied across almost 27,000 of its programmes, along with a proposed recalibration of limits for some of these. The Central Bank warned EML in May it was considering taking action against Trim, Co Meath-based PFS Card Services (Ireland) Ltd, which is part of Prepaid Financial Services(PFS), a company that the Australian group bought last year in a deal worth up to 186.5 million (216.2 million). PFS was founded by Noel and Valerie Moran in London in 2008. It became one of Europes largest issuers of emoney, with a presence in 25 countries by the time it was sold, and bases in Trim, Malta, London and Manchester. The Central Banks concerns relate to anti-money-laundering and counter-terrorism financing matters, risk, control frameworks and governance at PFS Card Services (Ireland). EML, which is in ongoing talks with the regulator on a remediation plan to address its concerns, said possible restrictions on its activities could be more limited than originally envisaged. However, the fintech added it still expects to be told to make changes that will hurt future growth As presently framed, EML considers that the directions could materially impact the European operations of the PFS business, it said. Costs and provisions EML has already incurred costs and provisions of over $11 million Australian dollars (7 million) to date in relation to the Central Banks investigation into its Irish unit, which accounted for 27 per cent of group revenues in the first three months of 2021. Its share price slumped by 46 per cent, wiping $850 million Australian dollars off its market value in May when the investigation was first announced. The fintech originally announced a deal to acquire PFS in a deal valued at $453.6 million Australian dollars. However, it subsequently secured a $189.1 million Australian dollars discount on the deal due to the impact of the Covid-19 crisis. EML last month received approval from French and British regulators to acquire Kildare-based Sentenial for an up-front enterprise value of 70 million, and an earn-out component of up to 40 million. Topics:

A NEW low-alcoholic brew has been launched to help raise funds for the Midlands Air Ambulance Charity. Birmingham Brewing Company has created the new brew to complement charity's festive gift range. The Stirchley based brewery is rolling out the barrel and pulling out all the hops to launch the new Sober Brummie in time for Christmas to help people stay sober and help raise funds for the lifesaving charity which races to the aid of critically ill and injured patients across the Midlands. Suitable for vegans and gluten free, the beverage has been brewed with the charitys core purpose in mind as people can enjoy a drink and still drive. The brewery is donating five per cent of each sale to support Midlands Air Ambulance Charitys critical care aircrew and vital work this Christmas. Pam Hodgetts, corporate partnerships manager for Midlands Air Ambulance Charity, said: Its thanks to local businesses showing their support that we are able to continue funding lifesaving missions across the Midlands. We are excited to try the Sober Brummie brew from Birmingham Brewing Company, even more so, knowing that a percentage of the sales will support our rapid response pre-hospital emergency service. Paul Harwood, owner and founder of Birmingham Brewing Company, added: After four years in development, were finally ready to take off with our low-alcohol Brummie beer. In contrast to most low and non-alcohol beers our 0.5 per cent ABV brew is brewed in a traditional way to retain its flavour, and like all our other beers, it is gluten free and vegan. There are always times when we need to be a Sober Brummie and we hope this is enjoyed by all. "We are delighted to partner with Midlands Air Ambulance Charity on this low alcohol brew, as it has a perfect synergy with the charitys mission. People can buy the new festive drink via website birminghambrewingcompany.co.uk/product-page/sober-brummieMAA. To shop the rest of Midlands Air Ambulance Charitys festive merchandise visit midlandsairambulance.com/shop/festive/c-24/c-73.

view in app Amazon finalized an $8.5 billion merger deal on Thursday for the acquisition of MGM, folding their vast catalog of film and TV into the already massive scroll of Amazon Studios and Amazon Prime offerings. According to an Amazon spokesperson sourced by Deadline Amazon plans to welcome all of MGM's existing employees, and aside from Mike Hopkins staying on as Senior Vice President of Amazon Studios and Amazon Prime, no further announcement has been given as to how, or if, things will restructure moving forward to include MGM upper-level management in the merger. Related: Amazon walkout: Dozens of warehouse workers protest low pay and bad working conditions "MGM has a nearly century-long legacy of producing exceptional entertainment, and we share their commitment to delivering a broad slate of original films and television shows to a global audience," said Hopkins. "We welcome MGM employees, creators, and talent to Prime Video and Amazon Studios, and we look forward to working together to create even more opportunities to deliver quality storytelling to our customers." Amazon Studios and Prime Video are part of the same Amazon division that also includes their podcast, music, audio books and video games, all led by Jeff Blackburn who heads up Global Media & Entertainment for Amazon. According to Variety Blackburn was an executive for Amazon for decades and parted ways with the company in February 2021 to join Bessemer Venture Partners, only to return later that summer to take on the position as head of Global Media & Entertainment. Want a daily wrap-up of all the news and commentary Salon has to offer? Subscribe to our morning newsletter Crash Course. "This deal is the first in a long-anticipated marriage of deep-pocketed big tech players and Hollywood," says Jill Goldsmith for Deadline. "MGM has been responsible for the creation of some of the most well-known and critically acclaimed films and television series of the past century," says Chris Brearton, chief operating officer of MGM. "We look forward to continuing that tradition as we head into this next chapter, coming together with the great team at Prime Video and Amazon Studios to provide audiences with the very best in entertainment for years to come." MGM brings with them power-punching titles such as "The Wizard of Oz," "Singin' In The Rain, "Ben Hur," and the James Bond franchise. "At one time, MGM was the most prestigious studio in Hollywood," Leonard Maltin, a film critic and historian, told CNN Business "It had a glory period that ran for decades." Read more:

attaches dispensers filled with CR-7 to the bees as they exit the hives. My initial article, An Early Stage Commercial Ag-Tech Disruptor; Bee Vectoring Technologies describes how the BVT system works and the company's initial commercialization steps. This article will provide an update on the investment thesis and focuses on the recent developments that will significantly impact BVT's revenue stream. The company is just entering its third growing season but has taken giant steps to scale by: widening the applicability of its product increasing products offered Territorial expansion and adding new crops Investment thesis There are many companies involved in bees for agricultural purposes. Looking at the websites for companies like Beeflow, BiobestBioBee, Koppert, and Aggrovio,you may think that these companies are competitors for Bee Vectoring Technologies. Remarkably, BVT partners or collaborates with all of these companies and just about every company involved in bee agriculture because no one else offers a regulatory approved, organic crop protector and fertilizer. Farmers have utilized bees for pollinating crops such as blueberries and strawberries for 9,000 years BVT is using these same bees to fertilize and provide disease and bug protection for crops. Despite the great strides that BVT has made in penetrating its targeted market, the stock price hasn't changed much since my original article in September last year. Growth stocks have been under pressuredue to rising interest rates. My investment thesis remains intact as the company remains on track with its commercial rollout. I expect the stock price to gain traction as the company becomes better known from the expected partnerships with the world's largest agricultural companies and continued revenue growth as the company enters its third growing season. Key potential drivers include: widening the applicability of its product increasing products offered expanding its territory and adding new crops Widening the applicability of its product BVT recently announcedthat after a year of testing, the application of CR-7 on soybean crops results in significant crop yield increase and reduction of disease. These results open up opportunities for BVT to collaborate with the agricultural industry giants in soybean farming. Consider that there are about 200,000 acres of blueberriesand nearly 400,000 acres of strawberries while there are 320,000,000 acres of soybeansin the world to put this development into perspective. The press release stated that eight companies are already involved in testing programs with CR-7, with one company conducting its independent testing. In addition, BVT is seeking to license the technology, which would bring in high margin revenue. BVT announced a memorandum of understandingwith BioSafe Systems where both companies will explore ways to collaborate using each other's products. BioSafe is predominantly involved with ground and seed spraying. Formal agreements with BioSafe will expose BVT to a brand new market opportunity with a U.S. $9 billion TAM. Increasing products offered Vectorite is designed so that different products can be stacked and delivered to crops by bees along with CR-7. In addition, the company has been conducting pilot testing with four companies since 2020 to add third-party solutions to its offerings menu. The first of these companies to reach an agreement with BVT, Biogard, has grantedthe company exclusive rights to sell their biological fungicide in Europe. CR-7 is pending and two years away from registration in Europe. The Biogard agreement allows BVT entry into the E.U. market through sales of an already registered product. BVT is continuing to work with the three remaining companies with the interest of developing additional crop products to be bundled for bee delivery. Territorial Expansion The territorial expansion has three different components: U.S. expansion Entering new territories through partnerships Entering new territories through registration U.S. expansion BVT received EPA regulatory approvalfor its technology in September 2019. In 2020 BVT began commercial activity serving blueberry and strawberry farmers in Georgia and Florida Florida's strawberry farmers could not compete with imported strawberries, and many filed for bankruptcy.Farmers tend to start with a small percentage of their farm acreage to compare the use of BVT with their everyday operations. BVT has retained 100% of its original blueberry farmers in Georgia who have now generally added their entire acreage to BVT, while BVT has been adding new customers in the same territory. Every U.S. state recognizes EPA registration except California, which requires its own registration process. Testing is required in each state because growing conditions vary. Completing each territory's registration requirements and testing process is another layer on BVT's moat for potential competitors to surmount. In 2021, BVT began serving blueberry farms in Michiganand New Jerseyand blueberry and caneberry farmsin Washington and Oregon.BVT gained California regulatory approvalfor its technology in December 2020, obtaining access to the majority of farm acreage in the U.S. Within months of California registration, BVT initiated testingfor blueberries, strawberries, caneberries, and almonds. Revenue from the new states and new crops should begin in 2023. The company also has ongoing testsfor cranberries in New Jersey, Massachusetts, Washington, and Wisconsin and testing sunflowers in Minnesota, North Dakota, and Idaho. Entering new territories through partnerships BVT has established local partners in Morocco, Turkey, South Africa, and Israel. These partners will foot the bill for registration in their respective countries in exchange for exclusive or preferential rights to BVT's technology within their respective territories. Only the Morocco partner has begun testing while the other partners are still in evaluation mode. Agriculture is the top industryof Morocco due to a long growing season. Entering new territories through registration BVT is pursuing registration in Switzerland, Mexico, Canada, the European Union, and Peru. The Swiss process should be completed in 2022 at the latest. In addition, BVT has been in discussion with two go-to-marketcompanies to pursue Swiss revenue this year and has established operations in Switzerlandwith an R&D center, office space, and land leased to a local farmer for demonstrations. Registration in Mexico, Canada, and the E.U. is expected to be completed by 2024 should the company raise sufficient capital to cover the costs. BVT has begun conducting testing in Mexico and is entering the E.U. market through partnerships. Financial and expectations There are about 117,000 shares. The company reported $1.7 million in cash and $782K in debt as of Dec. 31, 2021. The market cap is about $29K. BVT reported about $300K revenues for fiscal 2021, growing at about 80% over the prior year. P/S ratio is about 65X. Valuation ratios tend to be

Updated: January 13 2022, 3.31pm Entrepreneur Tony Banks has acquired Tayside Aviation. [[title]] An error occurred. Please try again. [[success]] Email address Sign up The Dundee-born founder of one of Scotlands largest care home groups is the new owner of Tayside Aviation. Tony Banks, founder of Balhousie Care Group, has acquired the 53-year-old business from the Watt family. Under the ownership of newly-formed ARB Aviation, the Watt family will continue to run Tayside Aviation, which provides training for pilots and aviation professionals, as an international aviation centre of excellence. The company hopes to become an international player in the aviation training sector. It aims to offer first-class facilities to attract both global and local candidates. Acquisition is an important step for Dundee Mr Banks said: ARB Aviation is excited to be on this journey with Tayside Aviation. It is an important step not only for Dundee and for Scotland, but also for the revival of the UKs aviation sector. We look forward to building on Tayside Aviations stellar reputation and to working with the team to take the company to even greater heights. Tayside Aviations chief flight instructor, James Whitby, with RAF cadet Holly Plummer. That includes working with international and UK partners, local high schools in Dundee and Dundee Airport. The business will also be exploring ways and means of lowering its carbon footprint. It is looking into converting its fleet to electric planes. Mr Banks added: This is the latest sign that Dundee is emerging as a business centre and an investment hub. It also puts the sunniest city in Scotland at the forefront of aviation training excellence. An exciting time for Tayside Aviation Tayside Aviation managing director Jim Watt hopes the new ownership can build upon the momentum of the firm. He said: We plan to work closely with Dundee Airport to raise the profile of what we see as an important Scottish transport hub. Jim Watt, managing director of Tayside Aviation. This is an exciting time for Tayside Aviation and for Dundee. Convener of Dundee City Councils city development committee Mark Flynn said the decision was not just a vote in confidence in the business, but in the city. As well as training private and commercial pilots, Tayside Aviation has also formed partnerships to expand its offerings. These include a BSc (Hons) Aviation Pilot degree through the University of Central Lancashire, while other partnerships include the Royal Air Force (RAF) and the International Air & Space Training Institute (IASTI). Chief flight instructor James Whitby said the partnerships would help develop cutting-edge training models and pathways into the industry. Already a subscriber?

0 A regional daily wants to bring an international sporting event to its patch after one of its columnists landed an exclusive on a bid for it. The Birmingham Mailis calling for the Invictus Games to be brought to Birmingham in 2025 after a bid by Birmingham City Council for the Games was revealed by sports presenter Gary Newbon in his weekly columnfor the newspaper. Wounded, injured and sick former and current servicemen and women compete across a variety of sports at the Games, which have been held four times across the world since 2014. The Mail splashed on the campaigns launch yesterday, pictured below. Editor Graeme Brown wrote in an accompanying editorial : The Invictus Games is an international sporting event for wounded, injured and sick servicemen and women, both serving and veterans. It has become a huge source of inspiration not only to those in the forces but to everyone in the country a huge celebration of talented people who just refuse to be stopped. Next year, the eyes of the world will be on Birmingham when the Commonwealth Games rolls into town and the city will shine brightly. People will come to a city with great sports facilities, return to superb hotels, enjoy a choice of wonderful bars and restaurants but more than all of that, they will enjoy a Brummie welcome. It will be a showcase for a city which has much to show and a reminder to everyone (Brummies included) that its where world-class things can happen. It would be fantastic opportunity for the city to honour heroes from around the world. But more important for our serving heroes it would be fantastic for them too. Related Topics

Share on whatsapp R1 RCM Inc. (NASDAQ:RCM) went up by 2.31% from its latest closing price compared to the recent 1-year high of $30.68. The companys stock price has collected 4.60% of gains in the last five trading sessions. The Wall Street Journalreported on 01/10/22 that Zynga, Lululemon, Virgin Orbit, Tilray: What to Watch When the Stock Market Opens Today Is It Worth Investing in R1 RCM Inc. (NASDAQ :RCM) Right Now? Plus, the 36-month beta value for RCM is at 0.77. Opinions of the stock are interesting as 7 analysts out of 8 who provided ratings for R1 RCM Inc. declared the stock was a buy, while 1 rated the stock as overweight, 0 rated it as hold, and 0 as sell. 3 Tiny Stocks Primed to Explode The world's greatest investor Warren Buffett has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential. We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns. . Sponsored The average price from analysts is $32.25, which is $5.34 above the current price. RCM currently public float of 134.48M and currently shorts hold a 4.23% ratio of that float. Today, the average trading volume of RCM was 1.09M shares. RCMs Market Performance RCM stocks went up by 4.60% for the week, with a monthly jump of 20.18% and a quarterly performance of 4.31%, while its annual performance rate touched -5.04%. The volatility ratio for the week stands at 6.71% while the volatility levels for the past 30 days are set at 4.85% for R1 RCM Inc.. The simple moving average for the period of the last 20 days is 10.77% for RCM stocks with a simple moving average of 16.45% for the last 200 days. Analysts Opinion of RCM Many brokerage firms have already submitted their reports for RCM stocks, with Deutsche Bank repeating the rating for RCM by listing it as a Buy. The predicted price for RCM in the upcoming period, according to Deutsche Bank is $30 based on the research report published on February 09th of the current year 2022. Jefferies, on the other hand, stated in their research note that they expect to see RCM reach a price target of $28. The rating they have provided for RCM stocks is Buy according to the report published on December 02nd, 2021. JP Morgan gave a rating of Overweight to RCM, setting the target price at $27 in the report published on October 14th of the previous year. RCM Trading at 11.19% from the 50-Day Moving Average After a stumble in the market that brought RCM to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -14.02% of loss for the given period. Volatility was left at 4.85%, however, over the last 30 days, the volatility rate increased by 6.71%, as shares surge +22.47% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +4.48% upper at present. During the last 5 trading sessions, RCM rose by +4.60%, which changed the moving average for the period of 200-days by +7.67% in comparison to the 20-day moving average, which settled at $24.06. In addition, R1 RCM Inc. saw 3.49% in overturn over a single year, with a tendency to cut further gains. Insider Trading Reports are indicating that there were more than several insider trading activities at RCM starting from MANDL ALEX, who sale 140,829 shares at the price of $25.40 back on Nov 18. After this action, MANDL ALEX now owns 93,871 shares of R1 RCM Inc., valued at $3,577,197 using the latest closing price. MANDL ALEX, the Director of R1 RCM Inc., sale 34,171 shares at $25.60 during a trade that took place back on Nov 17, which means that MANDL ALEX is holding 234,700 shares at $874,641 based on the most recent closing price. Stock Fundamentals for RCM Current profitability levels for the company are sitting at: +9.88 for the present operating margin +20.95 for the gross margin The net margin for R1 RCM Inc. stands at +6.59. Equity return is now at value -153.90, with -37.80 for asset returns.

Verboso Launches Full-Stack Online Speech Therapy Service Share Article utilizes an innovative approach to online speech therapy leveraging speech recognition to provide convenient therapy at lower costs. Verboso combines live therapy sessions with customized video games for home practice, providing services at multiple levels of care. Game screen of one of Verboso's games "Bo and Aro" Launching this service comes at an important moment when many children are struggling to access therapy due to the pandemic. CHICAGO (PRWEB) February 15, 2021 Verboso, a former Microsoft AI for Accessibility grantee, has launched a new virtual speech therapy platform that takes an innovative approach to online speech therapy, powered by speech recognition. The service combines face-to-face sessions with a licensed and certified speech-language pathologist, plus access to one-of-a-kind games that each client's therapist customizes to their needs to deliver feedback for home practice. These specially designed speech therapy games include speech recognition software that helps guide practice of correct speech skills learned in sessions. By leveraging this technology, Verboso can deliver therapy services at lower prices than traditional therapy. The technology also allows clients to securely message their therapist, review their progress and engage in therapy sessions all within a centralized portal. The convenience of therapy at home, along with access to specialized games, gives clients more control over when and how much they practice. By helping clients practice effectively between sessions, Verboso aims to help clients reach their speech goals quickly. Families can book a free screening today at verboso.com. How Verbosos full-stack online therapy works: Verboso provides therapy services at multiple levels of therapist involvement. Under this model, families access and pay for only what is needed to advance their speech therapy goals. To get started, families can sign up for a free screening with one of Verbosos certified speech language pathologists. Following the screening, Verboso offers a few therapy options and the therapist will recommend the appropriate path for each client. Families can sign up for a monthly subscription which provides access to two sessions with a certified speech therapist a month and access to the games to practice in between sessions. Alternatively, families can also purchase individual therapy sessions as frequently as needed and will get access to the games as well. Finally, in March of 2021, Verboso will release their Game Pass subscription tier at $10 per month. With this subscription, families can subscribe to the games, without needing to sign up for therapy sessions. Making the games accessible to families at a low monthly cost provides materials for those who may already have a therapist or just need some focused practice and repetition at home. Its critical that kids continue to have access to regular speech therapy services. Home practice is challenging for busy families, but it can make all the difference in how quickly a child advances through treatment. Our approach makes therapy accessible, and makes practice engaging and fun so that clients make progress. Says Amy Linde, MA, CCC-SLP, CCO at Verboso. Launching this service comes at an important moment when many children are struggling to access therapy due to the pandemic. Our goal is that by utilizing our technology we will be able to expand access to care in a cost effective and convenient way for families. Says Steven Arose, CEO at Verboso. Features and benefits of Verbosos online speech therapy service include. Cost savings for families Service options for various levels of therapy Convenient therapy access Engaging therapy games to boost motivation Increased data on performance for clients and therapists Service Pricing: Clients can get started with a free screening to assess their therapy needs. From there families can access the games and two 30 minute therapy sessions for a monthly subscription of $120 per month, or can schedule Pay-as-you go teletherapy sessions with Verboso therapists for $100 for a 45-minute session. Alternatively, families can subscribe to the Game Pass for just $10 per month. For more information on Verbosos services, visit verboso.com. About Verboso: Verboso is a technology company that is working to build a full-stack solution for speech therapy. Verboso is using speech recognition and video games controlled by speech exercises to help deliver its services. A former Microsoft AI for Accessibility grantee, Verboso is working to change the way speech therapy is delivered to improve access to care. Share article on social media or email: View article via:

Barnet, Enfield and Haringey Mental Health Trust on track to meet carbon emissions target St Mark's Hospital in Harrow. Photo: Google Street View comment Barnet's mental health trust is putting the planet first as records show it is on track to meet ambitious targets to cut carbon emissions by a third. It is likely Barnet, Enfield and Haringey Mental Health Trust will continue to achieve the Governments goal for the NHS to slash carbon dioxide emissions by 2020. The mental health trust is amongst 90 others which were on course to meet the target in 2017/18 which leaves more than 60 per cent failing to take their responsibilities seriously, the shadow health secretary claimed. John Mills, BEHs director of estates and facilities, is pleased and reassured by their performance. He explained the trust has reduced its CO2 emissions by 23 per cent since 2013. He said: Weve also designed sustainability and low carbon usage into our new development - most notably with the state-of-the-art mental health facility at St Anns which will open next summer. We recognise a clean, healthy environment, which promises a sustainable future, can help improve mental health. Thats why weve developed specific initiatives in our healthy transport and sustainable development management plans, including reviewing car parking and working with the London Wildlife Trust to improve open spaces. Under the Climate Change Act, trusts were tasked to cut emissions by 80 per cent by 2050, supported by reductions of 34 per cent by 2020, and 50 per cent by 2025. Despite this, a quarter of the 232 trusts included in the latest NHS records are not on track to meet the objectives, Newsquests Data Unit discovered. 46 per cent also still need a healthy transport plan, including the London Ambulance Service. The trust admitted its fleet causes most of its carbon footprint. By 2050, all vehicles in the services fleet should be zero emission capable. We have ambitious aims to reduce the environmental impact of our service while improving our

Genprex, Inc. (Genprex or the Company) (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced that the first patient was dosed in the Acclaim-1 clinical trial, an open-label, multi-center Phase 1/2 clinical trial evaluating the Companys lead drug candidate, REQORSA Immunogene Therapy, in combination with Tagrisso (osimertinib) in patients with late-stage non-small cell lung cancer (NSCLC) whose disease progressed after treatment with Tagrisso. In 2020, Genprex received U.S. Food and Drug Adminstrations (FDA) Fast Track Designation for treatment of the Acclaim-1 patient population. This is an exciting milestone for Genprex that we believe brings us one step closer to achieving our goal to validate the potential benefits of REQORSA in NSCLC patients who have life-limiting disease and few treatment options, stated Mark S. Berger, M.D., Chief Medical Officer of Genprex. Based on both the preclinical data and previous clinical data, REQORSA has the potential to improve the response to current targeted therapies, such as Tagrisso, for this study patient population. We look forward to continuing to advance this important trial." The Acclaim-1 clinical trial is an open-label, multi-center Phase 1/2 clinical trial evaluating the Companys lead drug candidate, REQORSA, in combination with Tagrisso in patients with late-stage NSCLC with activating epidermal growth factor receptor (EGFR) mutations whose disease progressed after treatment with Tagrisso. Genprex expects the Phase 1 portion of the Acclaim-1 trial to enroll up to 18 patients in a dose escalation study to determine the maximum tolerated dose of the combination. The Phase 2 portion of the study is expected to enroll approximately 74 patients to be randomized 1:1 to receive either REQORSA and Tagrisso combination therapy or Tagrisso monotherapy. The primary endpoint of the Phase 2 portion of the trial is progression-free survival, which is defined as time from randomization to progression or death. An interim analysis will be performed at 25 events. Genprex recently added four new clinical trial sites for the Acclaim-1 trial in order to accelerate enrollment, bringing the current number of sites to five. The Company expects to add additional sites for the Phase 2 portion of the trial. Genprex previously announced the Centralized Institutional Review Board (IRB) approvalfor the Acclaim-1 clinical trial in NSCLC. Additional information about the Acclaim-1 clinical trial can be found by visiting ClinicalTrials.gov Despite recent advances in immuno-oncology and other targeted treatments, NSCLC remains a significant unmet medical need as resistance to Tagrisso and other targeted therapies is a common clinical problem, said Dr. Berger. REQORSA is a pan-kinase inhibitor shown to inhibit both the EGFR and AKT oncogenic kinase pathways. We believe that REQORSAs multimodal activity will block emerging bypass pathways, reducing the probability that drug resistance develops. Preclinical Data at AACR 2021 Supportive preclinical data on the combination of REQORSA and Tagrisso (osimertinib) were presented by Genprex collaborators at the 2021 American Association of Clinical Research (AACR) annual meeting. The data showed that REQORSA and Tagrisso had a synergistic antitumor effect in EGFR mutant Tagrisso resistant NSCLC tumor xenograft models. In the preclinical study, researchers developed an osimertinib-resistant H1975-OsiR isogenic cell line through continuous exposure to osimertinib. Xenograft tumors from both H1975-parental and H1975-OsiR cells were grown in NSG mice and were treated with osimertinib. The combination of REQORSA and osimertinib showed a robust antitumor effect compared with single agent treatment groups against H1975-OsiR tumors. Tagrisso is a registered trademark of AstraZeneca plc and its largest selling drug with 2021 sales of over $5 billion. About REQORSA REQORSA Immunogene Therapy ( quaratusugene ozeplasmid ) for non-small cell lung cancer (NSCLC) uses Genprexs unique, proprietary ONCOPREX Nanoparticle Delivery System, which is the first systemic gene therapy delivery platform used for cancer in human clinical trials. The active ingredient in REQORSA is the TUSC2 gene, a tumor suppressor gene. REQORSA consists of the TUSC2 gene encapsulated in a nanoparticle made from lipid molecules with a net positive electrical charge. REQORSA is injected intravenously and can specifically target cancer cells, which generally have a negative electrical charge. Once REQORSA is taken up into a cancer cell, the TUSC2 gene is expressed, and the TUSC2 protein is capable of restoring certain defective functions arising in the cancer cell. REQORSA has a multimodal mechanism of action whereby it interrupts cell signaling pathways that cause replication and proliferation of cancer cells, re-establishes pathways for programmed cell death, or apoptosis, in cancer cells, and modulates the immune response against cancer cells. REQORSA has also been shown to block mechanisms that create drug resistance. About Genprex, Inc. Genprex, Inc. is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes. Genprexs technologies are designed to administer disease-fighting genes to provide new therapies for large patient populations with cancer and diabetes who currently have limited treatment options. Genprex works with world-class institutions and collaborators to develop drug candidates to further its pipeline of gene therapies in order to provide novel treatment approaches. Genprexs oncology program utilizes its unique, proprietary, non-viral ONCOPREX Nanoparticle Delivery System, which the Company believes is the first systemic gene therapy delivery platform used for cancer in humans. ONCOPREX encapsulates the gene-expressing plasmids using lipid nanoparticles. The resultant product is then administered intravenously, where it is then taken up by tumor cells that express proteins that are deficient. The Companys lead product candidate, REQORSA ( quaratusugene ozeplasmid ), is being evaluated as a treatment for non-small cell lung cancer (NSCLC). REQORSA has a multimodal mechanism of action that has been shown to interrupt cell signaling pathways that cause replication and proliferation of cancer cells; re-establish pathways for apoptosis, or programmed cell death, in cancer cells; and modulate the immune response against cancer cells. REQORSA has also been shown to block mechanisms that create drug resistance. In 2020, the U.S. Food and Drug Administration (FDA) granted Fast Track Designation for REQORSA for NSCLC in combination therapy with AstraZenecas Tagrisso (osimertinib) for patients with EFGR mutations whose tumors progressed after treatment with Tagrisso . In 2021, the FDA granted Fast Track Designation for REQORSA for NSCLC in combination therapy with Merck & Cos Keytruda (pembrolizumab)